# ICD-O-3 Supplemental Case List

+-----------------------------------------------------------------------+
| **Preface Notes for this List**                                       |
+-----------------------------------------------------------------------+
| 1\. This file is designed as a supplemental reportable list for       |
| cancer registries until such time as the                              |
|                                                                       |
| > ICD-O-3 Manuals are distributed. This list should be used in tandem |
| > with the ICD-O-2 Manual.                                            |
+-----------------------------------------------------------------------+
|                                                                       |
+-----------------------------------------------------------------------+
| 2\. The purpose of this list is to specify all new terms that will be |
| reportable tumors for diagnoses on or after January 1, 2001. Before   |
| using this list, registry personnel need to review and verify         |
| reportability at the facility or central registry level. For example, |
| the basal cell carcinomas (8091/3 & 8092/3) are listed because they   |
| are malignancies. Although these cancers could be reportable in a CoC |
| facility, they are not typically reportable to a central cancer       |
| registry.                                                             |
+-----------------------------------------------------------------------+
|                                                                       |
+-----------------------------------------------------------------------+
| 3\. This list contains two formats for the reportable tumors. One is  |
| ALPHA and one is NUMERIC.                                             |
+-----------------------------------------------------------------------+
|                                                                       |
+-----------------------------------------------------------------------+
| 4\. ALPHA is the *alphabetic sort* on the \"Terms as they appear in   |
| ICD-O-3.\" This sort is strictly as the term is listed in the ICD-O-3 |
| numeric list, not by key word.                                        |
+-----------------------------------------------------------------------+
|                                                                       |
+-----------------------------------------------------------------------+
| 5\. In NUMERIC, the sort is on the ICD-O-3 code *number.*             |
+-----------------------------------------------------------------------+
|                                                                       |
+-----------------------------------------------------------------------+
| 6\. If the term is a new synonym for a code that existed in ICD-O-2,  |
| the ICD-O-3 code number and the ICD-O-2 code number are identical.    |
+-----------------------------------------------------------------------+
|                                                                       |
+-----------------------------------------------------------------------+
| 7\. NOTE: This ICD-O-3 Supplemental Case List CONTAINS ONLY MALIGNANT |
| DIAGNOSES. For new benign and borderline terms, download the complete |
| file from the SEER web site.                                          |
+-----------------------------------------------------------------------+
|                                                                       |
+-----------------------------------------------------------------------+
| 8\. Specifically, the following tables are included:                  |
|                                                                       |
| > NEW ICD-O-3 CODES                                                   |
| >                                                                     |
| > NEW MORPHOLOGY TERMS AND SYNONYMS FOR EXISTING CODES                |
| >                                                                     |
| > TERMS THAT CHANGED FROM BORDERLINE TO MALIGNANT                     |
| >                                                                     |
| > TERMS THAT CHANGED MORPHOLOGY CODE                                  |
| >                                                                     |
| > TERMS THAT HAVE CHANGED FROM TUMOR-LIKE LESIONS TO NEOPLASMS        |
+-----------------------------------------------------------------------+
|                                                                       |
+-----------------------------------------------------------------------+
| 9\. Registries may need to make adjustments for other terms that are  |
| reportable by state requirement.                                      |
|                                                                       |
| Check with your state cancer registry.                                |
+-----------------------------------------------------------------------+
|                                                                       |
+-----------------------------------------------------------------------+

  ------------------- ----------------------------------------------------- -- -------------
                      **ALPHABETIC SORT**                                      

                                                                               

                      **Containing:**                                          

                      **NEW ICD-O-3 CODES**                                    

                      **NEW MORPHOLOGY TERMS AND SYNONYMS**                    

                      **TERMS THAT CHANGED FROM BORDERLINE TO MALIGNANT**      

                      **TERMS THAT CHANGED MORPHOLOGY CODE**                   

                      **TERMS THAT CHANGED FROM TUMOR-LIKE LESIONS TO          
                      NEOPLASMS**                                              

                                                                               

                                                                               

                      **Key:**                                                 

                      \* code used in United States (1995-2000) and in         
                      Canada (1997-2000)                                       

                      \*\* code used in United States and Canada               
                      (1998-2000)                                              

                      \-\-\-\-\-\-\-\-- code did (does) not exist              

                      [Note]{.underline}: Code 9421/1: Juvenile                
                      astrocytoma, pilocytic astrocytoma, and piloid           
                      astrocytoma is reportable as 9421/[3]{.underline} for    
                      cases diagnosed 2001 and after.                          

                      Code 8148/2, however, is not reportable: Glandular       
                      intraepithelial neoplasia, grade III.                    

                      Prostatic intraepithelial neoplasia, grade III; & PIN    
                      III. This term is not included in this list.             

                                                                               

  **ICD-O-2**         **Term as it appears in ICD-O-3**                        **ICD-O-3**

  \-\-\-\-\-\-\-\--   Acinar cell cystadenocarcinoma                           8551/3

  9870/3              Acute basophilic leukemia                                9870/3

  \-\-\-\-\-\-\-\--   Acute bilineal leukemia                                  9805/3

  \-\-\-\-\-\-\-\--   Acute biphenotypic leukemia                              9805/3

  9841/3              Acute erythremia \[obs\]                                 9840/3

  9841/3              Acute erythremic myelosis \[obs\]                        9840/3

  9840/3              Acute erythroid leukemia                                 9840/3

  9821/3              Acute lymphatic leukemia                                 9835/3

  9828/3 \*\*         Acute lymphoblastic leukemia, L2 type, NOS               9835/3

  9826/3              Acute lymphoblastic leukemia, mature B-cell type         9826/3

  9821/3              Acute lymphoblastic leukemia, NOS (See also M-9727/3)    9835/3

  \-\-\-\-\-\-\-\--   Acute lymphoblastic leukemia, precursor-cell type        9835/3

  \-\-\-\-\-\-\-\--   Acute lymphoblastic leukemia-lymphoma, NOS               9835/3

  9821/3              Acute lymphocytic leukemia                               9835/3

  9821/3              Acute lymphoid leukemia                                  9835/3

  \-\-\-\-\-\-\-\--   Acute mixed lineage leukemia                             9805/3

  9869/3 \*\*         Acute myeloblastic leukemia                              9872/3

  9865/3 \*\*         Acute myelocytic leukemia with maturation                9874/3

  9932/3              Acute myelofibrosis                                      9931/3

  \-\-\-\-\-\-\-\--   Acute myeloid leukemia with abnormal marrow              9871/3
                      eosinophils (includes all variants)                      

  \-\-\-\-\-\-\-\--   Acute myeloid leukemia with maturation                   9874/3

  \-\-\-\-\-\-\-\--   Acute myeloid leukemia with multilineage dysplasia       9895/3
                      (See also M-9984/3)                                      

  \-\-\-\-\-\-\-\--   Acute myeloid leukemia with prior myelodysplastic        9895/3
                      syndrome                                                 

  \-\-\-\-\-\-\-\--   Acute myeloid leukemia without maturation                9873/3

  \-\-\-\-\-\-\-\--   Acute myeloid leukemia without prior myelodysplastic     9895/3
                      syndrome                                                 

  \-\-\-\-\-\-\-\--   Acute myeloid leukemia, 11q23 abnormalities              9897/3

  \-\-\-\-\-\-\-\--   Acute myeloid leukemia, AML1(CBF-alpha)/ETO              9896/3

  \-\-\-\-\-\-\-\--   Acute myeloid leukemia, CBF-beta/MYH11                   9871/3

  \-\-\-\-\-\-\-\--   Acute myeloid leukemia, inv(16)(p13;q22)                 9871/3

  9840/3              Acute myeloid leukemia, M6 type                          9840/3

  \-\-\-\-\-\-\-\--   Acute myeloid leukemia, minimal differentiation          9872/3

  \-\-\-\-\-\-\-\--   Acute myeloid leukemia, MLL                              9897/3

  9861/3              Acute myeloid leukemia, NOS (FAB or WHO type not         9861/3
                      specified) (See also M-9930/3)                           

  9866/3              Acute myeloid leukemia, PML/RAR-alpha                    9866/3

  \-\-\-\-\-\-\-\--   Acute myeloid leukemia, t(8;21) (q22;q22)                9896/3

  9866/3              Acute myeloid leukemia, t(15;17)(q22;q11-12)             9866/3

  \-\-\-\-\-\-\-\--   Acute myeloid leukemia, t(16;16)(p13;q11)                9871/3

  \-\-\-\-\-\-\-\--   Acute myelomonocytic leukemia with abnormal              9871/3
                      eosinophils                                              

  9931/3              Acute myelosclerosis                                     9931/3

  9861/3              Acute non-lymphocytic leukemia                           9861/3

  9931/3              Acute panmyelosis with myelofibrosis (C42.1)             9931/3

  9722/3              Acute progressive histiocytosis X                        9754/3

  9866/3              Acute promyelocytic leukemia, PML/RAR-alpha              9866/3

  9866/3              Acute promyelocytic leukemia, t(15;17)(q22;q11-12)       9866/3

  \-\-\-\-\-\-\-\--   Adenocarcinoma combined with other types of carcinoma    8255/3

  \-\-\-\-\-\-\-\--   Adenocarcinoma of anal ducts (C21.1)                     8215/3

  \-\-\-\-\-\-\-\--   Adenocarcinoma of anal glands (C21.1)                    8215/3

  \-\-\-\-\-\-\-\--   Adenocarcinoma with mixed subtypes                       8255/3

  \-\-\-\-\-\-\-\--   Adenocarcinoma with neuroendocrine differentiation       8574/3

  \-\-\-\-\-\-\-\--   Adenocarcinoma, endocervical type                        8384/3

  \-\-\-\-\-\-\-\--   Adenoid basal carcinoma (C53.\_)                         8098/3

  8700/3              Adrenal medullary paraganglioma, malignant (C74.1)       8700/3

  9827/3              Adult T-cell leukemia/lymphoma (HTLV-1 positive)         9827/3
                      Includes all variants                                    

  \-\-\-\-\-\-\-\--   Aggressive NK-cell leukemia                              9948/3

  9961/3              Agnogenic myeloid metaplasia                             9961/3

  8077/2              AIN III (C21.1)                                          8077/2

  9864/3              Aleukemic granulocytic leukemia \[obs\]                  9860/3

  9804/3              Aleukemic leukemia, NOS \[obs\]                          9800/3

  9824/3              Aleukemic lymphatic leukemia \[obs\]                     9820/3

  9824/3              Aleukemic lymphocytic leukemia \[obs\]                   9820/3

  9824/3              Aleukemic lymphoid leukemia \[obs\]                      9820/3

  9894/3              Aleukemic monocytic leukemia \[obs\]                     9860/3

  9864/3              Aleukemic myelogenous leukemia \[obs\]                   9860/3

  9864/3              Aleukemic myeloid leukemia \[obs\]                       9860/3

  9290/3              Ameloblastic fibrodentinosarcoma                         9290/3

  9290/3              Ameloblastic fibro-odontosarcoma                         9290/3

  9840/3              AML M6                                                   9840/3

  8077/2              Anal intraepithelial neoplasia (C21.1)                   8077/2

  9680/3              Anaplastic large B-cell lymphoma                         9680/3

  9714/3              Anaplastic large cell lymphoma, CD30+                    9714/3

  9714/3              Anaplastic large cell lymphoma, NOS                      9714/3

  9714/3              Anaplastic large cell lymphoma, T cell and Null cell     9714/3
                      type                                                     

  9382/3              Anaplastic oligoastrocytoma (C71.\_)                     9382/3

  9713/3              Angiocentric T-cell lymphoma \[obs\]                     9719/3

  9712/3              Angioendotheliomatosis                                   9680/3

  9680/3              Angiotropic lymphoma                                     9680/3

  8803/3              Askin tumor                                              9365/3

  9400/3              Astrocytoma, low grade (C71.\_)                          9400/3

  \-\-\-\-\-\-\-\--   Atypical carcinoid tumor                                 8249/3

  \-\-\-\-\-\-\-\--   Atypical chronic myeloid leukemia, BCR/ABL negative      9876/3

  \-\-\-\-\-\-\-\--   Atypical chronic myeloid leukemia, Philadelphia          9876/3
                      chromosome (Ph1) negative                                

  \-\-\-\-\-\-\-\--   Atypical medullary carcinoma (C50.\_)                    8513/3

  \-\-\-\-\-\-\-\--   Atypical teratoid/rhabdoid tumor (C71.\_)                9508/3

  9591/3              B cell lymphoma, NOS                                     9591/3

  9826/3              B-ALL \[obs\]                                            9826/3

  \-\-\-\-\-\-\-\--   BALT lymphoma                                            9699/3

  \-\-\-\-\-\-\-\--   Basal cell carcinoma, desmoplastic type (C44.\_)         8092/3

  \-\-\-\-\-\-\-\--   Basal cell carcinoma, micronodular (C44.\_)              8097/3

  \-\-\-\-\-\-\-\--   Basal cell carcinoma, morpheic (C44.\_)                  8092/3

  \-\-\-\-\-\-\-\--   Basal cell carcinoma, nodular (C44.\_)                   8097/3

  \-\-\-\-\-\-\-\--   Basaloid squamous cell carcinoma                         8083/3

  9823/3              B-cell chronic lymphocytic leukemia/small lymphocytic    9823/3
                      lymphoma (See also M-9670/3)                             

  \-\-\-\-\-\-\-\--   Bellini duct carcinoma (C64.9)                           8319/3

  \-\-\-\-\-\-\-\--   Bronchial-associated lymphoid tissue lymphoma            9699/3

  \-\-\-\-\-\-\-\--   Bronchiolo-alveolar carcinoma, Clara cell (C34.\_)       8252/3

  \-\-\-\-\-\-\-\--   Bronchiolo-alveolar carcinoma, Clara cell and goblet     8254/3
                      cell type (C34.\_)                                       

  \-\-\-\-\-\-\-\--   Bronchiolo-alveolar carcinoma, goblet cell type          8253/3
                      (C34.\_)                                                 

  \-\-\-\-\-\-\-\--   Bronchiolo-alveolar carcinoma, indeterminate type        8254/3
                      (C34.\_)                                                 

  \-\-\-\-\-\-\-\--   Bronchiolo-alveolar carcinoma, mixed mucinous and        8254/3
                      non-mucinous (C34.\_)                                    

  \-\-\-\-\-\-\-\--   Bronchiolo-alveolar carcinoma, mucinous (C34.\_)         8253/3

  \-\-\-\-\-\-\-\--   Bronchiolo-alveolar carcinoma, non-mucinous (C34.\_)     8252/3

  \-\-\-\-\-\-\-\--   Bronchiolo-alveolar carcinoma, type II pneumocyte        8252/3
                      (C34.\_)                                                 

  \-\-\-\-\-\-\-\--   Bronchiolo-alveolar carcinoma, type II pneumocyte and    8254/3
                      goblet cell type (C34.\_)                                

  9826/3              Burkitt cell leukemia (See also M-9687/3)                9826/3

  9687/3              Burkitt-like lymphoma                                    9687/3

  8510/3              C cell carcinoma (C73.9)                                 8345/3

  \-\-\-\-\-\-\-\--   C-ALL                                                    9836/3

  \-\-\-\-\-\-\-\--   Carcinofibroma                                           8934/3

  \-\-\-\-\-\-\-\--   Carcinoma showing thymus-like differentiation            8589/3

  \-\-\-\-\-\-\-\--   Carcinoma showing thymus-like element                    8589/3

  \-\-\-\-\-\-\-\--   Carcinoma with neuroendocrine differentiation            8574/3

  \-\-\-\-\-\-\-\--   Carcinoma with osteoclast-like giant cells               8035/3

  \-\-\-\-\-\-\-\--   CASTLE                                                   8589/3

  9391/3              Cellular ependymoma (C71.\_)                             9391/3

  9500/3              Central neuroblastoma (C71.\_)                           9500/3

  \-\-\-\-\-\-\-\--   Central osteosarcoma (C40.\_, C41.\_)                    9186/3

  9473/3              Central primitive neuroectodermal tumor, NOS (C71.\_)    9473/3

  \-\-\-\-\-\-\-\--   Chondroid chordoma                                       9371/3

  9390/3              Choroid plexus carcinoma (C71.5)                         9390/3

  \-\-\-\-\-\-\-\--   Chromophobe cell renal carcinoma (C64.9)                 8317/3

  \-\-\-\-\-\-\-\--   Chronic eosinophilic leukemia                            9964/3

  9842/3              Chronic erythremia \[obs\]                               9950/3

  \-\-\-\-\-\-\-\--   Chronic granulocytic leukemia, BCR/ABL                   9875/3

  \-\-\-\-\-\-\-\--   Chronic granulocytic leukemia, Philadelphia              9875/3
                      chromosome (Ph1) positive                                

  \-\-\-\-\-\-\-\--   Chronic granulocytic leukemia, t(9;22)(q34;q11)          9875/3

  9961/3              Chronic idiopathic myelofibrosis                         9961/3

  9803/3              Chronic leukemia, NOS \[obs\]                            9800/3

  9823/3              Chronic lymphocytic leukemia, B-cell type (includes      9823/3
                      all variants of BCLL)                                    

  9893/3              Chronic monocytic leukemia \[obs\]                       9860/3

  \-\-\-\-\-\-\-\--   Chronic myelogenous leukemia, BCR/ABL positive           9875/3

  \-\-\-\-\-\-\-\--   Chronic myelogenous leukemia, Philadelphia chromosome    9875/3
                      (Ph1) positive                                           

  \-\-\-\-\-\-\-\--   Chronic myelogenous leukemia, t(9;22)(q34;q11)           9875/3

  \-\-\-\-\-\-\-\--   Chronic myelomonocytic leukemia in transformation        9945/3
                      \[obs\]                                                  

  9868/3              Chronic myelomonocytic leukemia, NOS                     9945/3

  \-\-\-\-\-\-\-\--   Chronic myelomonocytic leukemia, Type I                  9945/3

  \-\-\-\-\-\-\-\--   Chronic myelomonocytic leukemia, Type II                 9945/3

  9960/1              Chronic myeloproliferative disease, NOS                  9960/3

  9960/1              Chronic myeloproliferative disorder                      9960/3

  \-\-\-\-\-\-\-\--   Chronic neutrophilic leukemia                            9963/3

  9654/3              Classical Hodgkin lymphoma, lymphocyte depletion,        9654/3
                      diffuse fibrosis                                         

  9653/3              Classical Hodgkin lymphoma, lymphocyte depletion, NOS    9653/3

  9655/3              Classical Hodgkin lymphoma, lymphocyte depletion,        9655/3
                      reticular                                                

  \-\-\-\-\-\-\-\--   Classical Hodgkin lymphoma, lymphocyte-rich              9651/3

  9652/3              Classical Hodgkin lymphoma, mixed cellularity, NOS       9652/3

  9664/3              Classical Hodgkin lymphoma, nodular sclerosis,           9664/3
                      cellular phase                                           

  9665/3              Classical Hodgkin lymphoma, nodular sclerosis, grade     9665/3
                      1                                                        

  9667/3              Classical Hodgkin lymphoma, nodular sclerosis, grade     9667/3
                      2                                                        

  9663/3              Classical Hodgkin lymphoma, nodular sclerosis, NOS       9663/3

  8313/3              Clear cell adenocarcinofibroma (C56.9)                   8313/3

  \-\-\-\-\-\-\-\--   Clear cell chondrosarcoma (C40.\_, C41.\_)               9242/3

  8313/3              Clear cell cystadenocarcinofibroma (C56.9)               8313/3

  9391/3              Clear cell ependymoma (C71.\_)                           9391/3

  \-\-\-\-\-\-\-\--   Collecting duct carcinoma (C64.9)                        8319/3

  8045/3              Combined small cell carcinoma                            8045/3

  8045/3              Combined small cell-adenocarcinoma                       8045/3

  8045/3              Combined small cell-squamous cell carcinoma              8045/3

  \-\-\-\-\-\-\-\--   Common ALL                                               9836/3

  \-\-\-\-\-\-\-\--   Common precursor B ALL                                   9836/3

  \-\-\-\-\-\-\-\--   Composite Hodgkin and non-Hodgkin lymphoma               9596/3

  8051/3              Condylomatous carcinoma                                  8051/3

  \-\-\-\-\-\-\-\--   Conventional central osteosarcoma (C40.\_, C41.\_)       9186/3

  \-\-\-\-\-\-\-\--   Cortical T ALL                                           9837/3

  9473/3              CPNET (C71.\_)                                           9473/3

  9709/3              Cutaneous T-cell lymphoma, NOS (C44.\_)                  9709/3

  8121/3              Cylindrical cell carcinoma (C30.0, C31.\_)               8121/3

  \-\-\-\-\-\-\-\--   Cyst-associated renal cell carcinoma (C64.9)             8316/3

  \-\-\-\-\-\-\-\--   Cystic hypersecretory carcinoma (C50.\_)                 8508/3

  8501/2              DCIS, comedo type (C50.\_)                               8501/2

  8500/2              DCIS, NOS (C50.\_)                                       8500/2

  8503/2              DCIS, papillary (C50.\_)                                 8503/2

  \-\-\-\-\-\-\-\--   Dedifferentiated chondrosarcoma (C40.\_, C41.\_)         9243/3

  \-\-\-\-\-\-\-\--   Dedifferentiated chordoma                                9372/3

  \-\-\-\-\-\-\-\--   Dendritic cell sarcoma, NOS                              9757/3

  9084/3              Dermoid cyst with secondary tumor                        9084/3

  8745/3              Desmoplastic melanoma, amelanotic (C44.\_)               8745/3

  9051/3              Desmoplastic mesothelioma                                9051/3

  9471/3              Desmoplastic nodular medulloblastoma (C71.6)             9471/3

  \-\-\-\-\-\-\-\--   Desmoplastic small round cell tumor                      8806/3

  9841/3              Di Guglielmo disease \[obs\]                             9840/3

  9400/3              Diffuse astrocytoma (C71.\_)                             9400/3

  9400/3              Diffuse astrocytoma, low grade (C71.\_)                  9400/3

  8408/3              Digital papillary adenocarcinoma (C44.\_)                8408/3

  9501/3              Diktyoma, malignant (C69.\_)                             9501/3

  8500/2              DIN 3 (C50.\_)                                           8500/2

  \-\-\-\-\-\-\-\--   Duct carcinoma, desmoplastic type                        8514/3

  8501/2              Ductal carcinoma in situ, comedo type (C50.\_)           8501/2

  8201/2              Ductal carcinoma in situ, cribriform type (C50.\_)       8201/2

  \-\-\-\-\-\-\-\--   Ductal carcinoma in situ, micropapillary (C50.\_)        8507/2

  8500/2              Ductal carcinoma in situ, NOS (C50.\_)                   8500/2

  8503/2              Ductal carcinoma in situ, papillary (C50.\_)             8503/2

  8230/2              Ductal carcinoma in situ, solid type (C50.\_)            8230/2

  8201/3              Ductal carcinoma, cribriform type (C50.\_)               8201/3

  8500/2              Ductal intraepithelial neoplasia 3 (C50.\_)              8500/2

  8241/3              EC cell carcinoid                                        8241/3

  \-\-\-\-\-\-\-\--   Eccrine adenocarcinoma (C44.\_)                          8413/3

  8408/3              Eccrine papillary adenocarcinoma (C44.\_)                8408/3

  \-\-\-\-\-\-\-\--   Eccrine poroma, malignant                                8409/3

  \-\-\-\-\-\-\-\--   ECL cell carcinoid, malignant                            8242/3

  \-\-\-\-\-\-\-\--   Ectomesenchymoma                                         8921/3

  8910/3              Embryonal rhabdomyosarcoma, pleomorphic                  8910/3

  8931/1              Endolymphatic stromal myosis (C54.1)                     8931/3

  8930/3              Endometrial stromal sarcoma, high grade (C54.1)          8930/3

  8931/1              Endometrial stromal sarcoma, low grade (C54.1)           8931/3

  8931/1              Endometrial stromatosis (C54.1)                          8931/3

  \-\-\-\-\-\-\-\--   Endometrioid adenocarcinoma, ciliated cell variant       8383/3

  \-\-\-\-\-\-\-\--   Endometrioid adenocarcinoma, secretory variant           8382/3
                      (C56.9)                                                  

  8241/3              Enterochromaffin cell carcinoid                          8241/3

  \-\-\-\-\-\-\-\--   Enterochromaffin-like cell tumor, malignant              8242/3

  \-\-\-\-\-\-\-\--   Enteroglucagonoma, malignant                             8157/3

  \-\-\-\-\-\-\-\--   Enteropathy associated T-cell lymphoma                   9717/3

  \-\-\-\-\-\-\-\--   Enteropathy type intestinal T-cell lymphoma              9717/3

  9880/3              Eosinophilic leukemia                                    9860/3

  9540/3              Epithelioid MPNST                                        9540/3

  9962/1              Essential hemorrhagic thrombocythemia                    9962/3

  9962/1              Essential thrombocythemia                                9962/3

  9821/3              FAB L1                                                   9835/3

  9828/3 \*\*         FAB L2                                                   9835/3

  9826/3              FAB L3 \[obs\]                                           9826/3

  9872/3 \*\*         FAB M0                                                   9872/3

  9873/3 \*\*         FAB M1                                                   9873/3

  \-\-\-\-\-\-\-\--   FAB M2, AML1(CBF-alpha)/ETO                              9896/3

  9874/3 \*\*         FAB M2, NOS                                              9874/3

  \-\-\-\-\-\-\-\--   FAB M2, t(8;21)(q22;q22)                                 9896/3

  9866/3              FAB M3 (includes all variants)                           9866/3

  9867/3              FAB M4                                                   9867/3

  9871/3 \*\*         FAB M4Eo                                                 9871/3

  9891/3              FAB M5 (includes all variants)                           9891/3

  9840/3              FAB M6                                                   9840/3

  9910/3              FAB M7                                                   9910/3

  8333/3              Fetal adenocarcinoma                                     8333/3

  8857/3              Fibroblastic liposarcoma                                 8857/3

  8093/3              Fibroepithelial basal cell carcinoma, Pinkus type        8093/3

  8093/3              Fibroepithelioma of Pinkus type                          8093/3

  8093/3              Fibroepithelioma, NOS                                    8093/3

  \-\-\-\-\-\-\-\--   Follicular carcinoma, encapsulated (C73.9)               8335/3

  \-\-\-\-\-\-\-\--   Follicular carcinoma, minimally invasive (C73.9)         8335/3

  8290/3              Follicular carcinoma, oxyphilic cell (C73.9)             8290/3

  \-\-\-\-\-\-\-\--   Follicular dendritic cell sarcoma                        9758/3

  \-\-\-\-\-\-\-\--   Follicular dendritic cell tumor                          9758/3

  9695/3              Follicular lymphoma, grade 1                             9695/3

  9691/3              Follicular lymphoma, grade 2                             9691/3

  9698/3              Follicular lymphoma, grade 3                             9698/3

  9690/3              Follicular lymphoma, NOS (See also M-9675/3)             9690/3

  9763/3              Franklin disease                                         9762/3

  9763/3              Gamma heavy chain disease                                9762/3

  9505/3              Ganglioglioma, anaplastic                                9505/3

  8153/3              Gastrin cell tumor, malignant                            8153/3

  \-\-\-\-\-\-\-\--   Gastrointestinal stromal sarcoma                         8936/3

  \-\-\-\-\-\-\-\--   Gastrointestinal stromal tumor, malignant                8936/3

  \-\-\-\-\-\-\-\--   Germ cell tumor, nonseminomatous (C62.\_)                9065/3

  \-\-\-\-\-\-\-\--   Giant cell tumor of tendon sheath, malignant (C49.\_)    9252/3

  \-\-\-\-\-\-\-\--   GIST, malignant                                          8936/3

  \-\-\-\-\-\-\-\--   Glassy cell carcinoma                                    8015/3

  8711/3              Glomus tumor, malignant                                  8711/3

  8620/3              Granulosa cell tumor, sarcomatoid (C56.9)                8620/3

  9940/3              Hairy cell leukemia variant                              9940/3

  9762/3              Heavy chain disease, NOS                                 9762/3

  \-\-\-\-\-\-\-\--   Hepatocellular carcinoma, clear cell type (C22.0)        8174/3

  \-\-\-\-\-\-\-\--   Hepatocellular carcinoma, pleomorphic type (C22.0)       8175/3

  \-\-\-\-\-\-\-\--   Hepatocellular carcinoma, sarcomatoid (C22.0)            8173/3

  \-\-\-\-\-\-\-\--   Hepatocellular carcinoma, scirrhous (C22.0)              8172/3

  \-\-\-\-\-\-\-\--   Hepatocellular carcinoma, spindle cell variant           8173/3
                      (C22.0)                                                  

  \-\-\-\-\-\-\-\--   Hepatoid adenocarcinoma                                  8576/3

  \-\-\-\-\-\-\-\--   Hepatoid carcinoma                                       8576/3

  9071/3              Hepatoid yolk sac tumor                                  9071/3

  \-\-\-\-\-\-\-\--   Hepatosplenic gamma-delta cell lymphoma                  9716/3

  8402/3              Hidradenocarcinoma (C44.\_)                              8402/3

  \-\-\-\-\-\-\-\--   High grade surface osteosarcoma (C40.\_, C41.\_)         9194/3

  9680/3              Histiocyte-rich large B-cell lymphoma                    9680/3

  9720/3              Histiocytic medullary reticulosis \[obs\]                9750/3

  \-\-\-\-\-\-\-\--   Histiocytic sarcoma                                      9755/3

  9658/3              Hodgkin disease, lymphocyte predominance, diffuse        9651/3
                      \[obs\]                                                  

  9657/3              Hodgkin disease, lymphocyte predominance, NOS \[obs\]    9651/3

  9657/3              Hodgkin disease, lymphocytic-histiocytic predominance    9651/3
                      \[obs\]                                                  

  9666/3              Hodgkin disease, nodular sclerosis, mixed cellularity    9665/3

  \-\-\-\-\-\-\-\--   Hodgkin lymphoma, lymphocyte-rich                        9651/3

  9665/3              Hodgkin lymphoma, nodular sclerosis, grade 1             9665/3

  9667/3              Hodgkin lymphoma, nodular sclerosis, grade 2             9667/3

  9660/3              Hodgkin paragranuloma, nodular \[obs\]                   9659/3

  9660/3              Hodgkin paragranuloma, NOS \[obs\]                       9659/3

  \-\-\-\-\-\-\-\--   Hypereosinophilic syndrome                               9964/3

  9962/1              Idiopathic hemorrhagic thrombocythemia                   9962/3

  9962/1              Idiopathic thrombocythemia                               9962/3

  9080/3              Immature teratoma, malignant                             9080/3

  \-\-\-\-\-\-\-\--   Infiltrating basal cell carcinoma, non-sclerosing        8092/3
                      (C44.\_)                                                 

  \-\-\-\-\-\-\-\--   Infiltrating basal cell carcinoma, NOS (C44.\_)          8092/3

  \-\-\-\-\-\-\-\--   Infiltrating basal cell carcinoma, sclerosing            8092/3
                      (C44.\_)                                                 

  \-\-\-\-\-\-\-\--   Infiltrating duct and colloid carcinoma (C50.\_)         8523/3

  \-\-\-\-\-\-\-\--   Infiltrating duct and cribriform carcinoma (C50.\_)      8523/3

  \-\-\-\-\-\-\-\--   Infiltrating duct and mucinous carcinoma (C50.\_)        8523/3

  \-\-\-\-\-\-\-\--   Infiltrating duct and tubular carcinoma (C50.\_)         8523/3

  \-\-\-\-\-\-\-\--   Infiltrating duct mixed with other types of carcinoma    8523/3
                      (C50.\_)                                                 

  8522/3              Infiltrating lobular carcinoma and ductal carcinoma      8522/3
                      in situ (C50.\_)                                         

  \-\-\-\-\-\-\-\--   Infiltrating lobular mixed with other types of           8524/3
                      carcinoma (C50.\_)                                       

  8503/3              Infiltrating papillary adenocarcinoma                    8503/3

  8851/3              Inflammatory liposarcoma                                 8851/3

  \-\-\-\-\-\-\-\--   Insular carcinoma (C73.9)                                8337/3

  \-\-\-\-\-\-\-\--   Interdigitating cell sarcoma                             9757/3

  \-\-\-\-\-\-\-\--   Interdigitating dendritic cell sarcoma                   9757/3

  \-\-\-\-\-\-\-\--   Intestinal T-cell lymphoma                               9717/3

  \-\-\-\-\-\-\-\--   Intracortical osteosarcoma (C40.\_, C41.\_)              9195/3

  \-\-\-\-\-\-\-\--   Intraductal carcinoma, clinging (C50.\_)                 8507/2

  8230/2              Intraductal carcinoma, solid type                        8230/2

  \-\-\-\-\-\-\-\--   Intraductal micropapillary carcinoma (C50.\_)            8507/2

  \-\-\-\-\-\-\-\--   Intraductal papillary-mucinous carcinoma, invasive       8453/3
                      (C25.\_)                                                 

  \-\-\-\-\-\-\-\--   Intraductal papillary-mucinous carcinoma,                8453/2
                      non-invasive (C25.\_)                                    

  \-\-\-\-\-\-\-\--   Intraosseous low grade osteosarcoma (C40.\_, C41.\_)     9187/3

  \-\-\-\-\-\-\-\--   Intraosseous well differentiated osteosarcoma            9187/3
                      (C40.\_, C41.\_)                                         

  9064/2              Intratubular germ cell neoplasia (C62.\_)                9064/2

  9064/2              Intratubular malignant germ cells (C62.\_)               9064/2

  9680/3              Intravascular B-cell lymphoma                            9680/3

  9134/1              Intravascular bronchial alveolar tumor (C34.\_)          9133/3
                      \[obs\]                                                  

  9680/3              Intravascular large B-cell lymphoma (C49.9)              9680/3

  9421/3              Juvenile astrocytoma (C71.\_)                            9421/1

  \-\-\-\-\-\-\-\--   Juvenile chronic myelomonocytic leukemia                 9946/3

  \-\-\-\-\-\-\-\--   Juvenile myelomonocytic leukemia                         9946/3

  9190/3              Juxtacortical osteosarcoma (C40.\_, C41.\_)              9192/3

  \-\-\-\-\-\-\-\--   Langerhans cell histiocytosis, disseminated              9754/3

  \-\-\-\-\-\-\-\--   Langerhans cell histiocytosis, generalized               9754/3

  \-\-\-\-\-\-\-\--   Langerhans cell sarcoma                                  9756/3

  \-\-\-\-\-\-\-\--   Large cell carcinoma with rhabdoid phenotype             8014/3

  \-\-\-\-\-\-\-\--   Large cell medulloblastoma (C71.6)                       9474/3

  \-\-\-\-\-\-\-\--   Large cell neuroendocrine carcinoma                      8013/3

  8520/2              LCIS, NOS (C50.\_)                                       8520/2

  9704/3              Lennert lymphoma                                         9702/3

  9722/3              Letterer-Siwe disease                                    9754/3

  9941/3              Leukemic reticuloendotheliosis                           9940/3

  8851/3              Lipoma-like liposarcoma                                  8851/3

  9821/3              Lymphoblastic leukemia, NOS                              9835/3

  9685/3              Lymphoblastoma \[obs\]                                   9727/3

  9704/3              Lymphoepithelioid lymphoma                               9702/3

  8082/3              Lymphoepithelioma-like carcinoma                         8082/3

  \-\-\-\-\-\-\-\--   Lymphomatoid papulosis (C44.\_)                          9718/3

  9850/3              Lymphosarcoma cell leukemia \[obs\]                      9820/3

  9592/3              Lymphosarcoma, diffuse \[obs\]                           9591/3

  9592/3              Lymphosarcoma, NOS \[obs\]                               9591/3

  9840/3              M6A                                                      9840/3

  9840/3              M6B                                                      9840/3

  8940/3              Malignant chondroid syringoma (C44.\_)                   8940/3

  \-\-\-\-\-\-\-\--   Malignant cystic nephroma (C64.9)                        8959/3

  8403/3              Malignant eccrine spiradenoma (C44.\_)                   8403/3

  9720/3              Malignant histiocytosis                                  9750/3

  9683/3              Malignant lymphoma, centroblastic, diffuse               9680/3

  9697/3              Malignant lymphoma, centroblastic, follicular            9698/3

  9683/3              Malignant lymphoma, centroblastic, NOS                   9680/3

  9676/3              Malignant lymphoma, centroblastic-centrocytic,           9675/3
                      diffuse \[obs\]                                          

  9692/3              Malignant lymphoma, centroblastic-centrocytic,           9690/3
                      follicular                                               

  9676/3              Malignant lymphoma, centroblastic-centrocytic, NOS       9675/3
                      \[obs\]                                                  

  9674/3              Malignant lymphoma, centrocytic \[obs\]                  9673/3

  9672/3              Malignant lymphoma, cleaved cell, NOS \[obs\]            9591/3

  9685/3              Malignant lymphoma, convoluted cell \[obs\]              9727/3

  9595/3              Malignant lymphoma, diffuse, NOS                         9591/3

  9690/3              Malignant lymphoma, follicle center, follicular          9690/3

  9690/3              Malignant lymphoma, follicle center, NOS                 9690/3

  9680/3              Malignant lymphoma, large B-cell, diffuse,               9680/3
                      centroblastic, NOS                                       

  9684/3              Malignant lymphoma, large B-cell, diffuse,               9684/3
                      immunoblastic, NOS                                       

  9681/3              Malignant lymphoma, large cell, cleaved, diffuse         9680/3

  9681/3              Malignant lymphoma, large cell, cleaved, NOS             9680/3

  9682/3              Malignant lymphoma, large cell, noncleaved, diffuse      9680/3

  9682/3              Malignant lymphoma, large cell, noncleaved, NOS          9680/3

  9681/3              Malignant lymphoma, large cleaved cell, NOS              9680/3

  9685/3              Malignant lymphoma, lymphoblastic (See also 9821/3)      9727/3

  9694/3              Malignant lymphoma, lymphocytic, intermediate            9591/3
                      differentiation, nodular \[obs\]                         

  9672/3              Malignant lymphoma, lymphocytic, poorly                  9591/3
                      differentiated, diffuse \[obs\]                          

  9696/3              Malignant lymphoma, lymphocytic, poorly                  9695/3
                      differentiated, nodular \[obs\]                          

  9693/3              Malignant lymphoma, lymphocytic, well differentiated,    9698/3
                      nodular \[obs\]                                          

  9682/3              Malignant lymphoma, noncleaved, diffuse, NOS             9680/3

  9682/3              Malignant lymphoma, noncleaved, NOS                      9680/3

  9670/3              Malignant lymphoma, small B lymphocytic, NOS (See        9670/3
                      also M-9823/3)                                           

  9670/3              Malignant lymphoma, small cell diffuse                   9670/3

  9686/3              Malignant lymphoma, small cell, noncleaved, diffuse      9591/3
                      \[obs\]                                                  

  9672/3              Malignant lymphoma, small cleaved cell, diffuse          9591/3
                      \[obs\]                                                  

  9672/3              Malignant lymphoma, small cleaved cell, NOS \[obs\]      9591/3

  9670/3              Malignant lymphoma, small lymphocytic, NOS               9670/3

  9686/3              Malignant lymphoma, undifferentiated cell type, NOS      9591/3
                      \[obs\]                                                  

  9686/3              Malignant lymphoma, undifferentiated cell,               9591/3
                      non-Burkitt \[obs\]                                      

  9677/3              Malignant lymphomatous polyposis \[obs\]                 9673/3

  8761/3              Malignant melanoma in congenital melanocytic nevus       8761/3
                      (C44.\_)                                                 

  9713/3              Malignant midline reticulosis \[obs\]                    9719/3

  9015/3              Malignant mucinous adenofibroma (C56.9)                  9015/3

  9015/3              Malignant mucinous cystadenofibroma (C56.9)              9015/3

  \-\-\-\-\-\-\-\--   Malignant multilocular cystic nephroma (C64.9)           8959/3

  9931/3              Malignant myelosclerosis \[obs\]                         9931/3

  8982/3              Malignant myoepithelioma                                 8982/3

  9540/3              Malignant peripheral nerve sheath tumor                  9540/3

  9561/3              Malignant peripheral nerve sheath tumor with             9561/3
                      rhabdomyoblastic differentiation                         

  9713/3              Malignant reticulosis, NOS \[obs\]                       9719/3

  8963/3              Malignant rhabdoid tumor                                 8963/3

  9014/3              Malignant serous adenofibroma (C56.9)                    9014/3

  9014/3              Malignant serous cystadenofibroma (C56.9)                9014/3

  \-\-\-\-\-\-\-\--   Malignant tenosynovial giant cell tumor (C49.\_)         9252/3

  \-\-\-\-\-\-\-\--   Malignant tumor, clear cell type                         8005/3

  9715/3 \*           MALT lymphoma                                            9699/3

  9673/3              Mantle cell lymphoma                                     9673/3

  \-\-\-\-\-\-\-\--   Marginal zone B-cell lymphoma, NOS                       9699/3

  9710/3 \*           Marginal zone lymphoma, NOS                              9699/3

  9900/3              Mast cell leukemia (C42.1)                               9742/3

  8110/3              Matrical carcinoma (C44.\_)                              8110/3

  \-\-\-\-\-\-\-\--   Mature T ALL                                             9837/3

  9702/3              Mature T-cell lymphoma, NOS                              9702/3

  \-\-\-\-\-\-\-\--   Mediastinal large B-cell lymphoma (C38.3)                9679/3

  8511/3              Medullary carcinoma with amyloid stroma (C73.9)          8345/3

  \-\-\-\-\-\-\-\--   Medullary osteosarcoma (C40.\_, C41.\_)                  9186/3

  9961/1              Megakaryocytic myelosclerosis                            9961/3

  9470/3              Melanotic medulloblastoma (C71.6)                        9470/3

  9540/3              Melanotic MPNST                                          9540/3

  9540/3              Melanotic psammomatous MPNST                             9540/3

  \-\-\-\-\-\-\-\--   Meningeal melanomatosis (C70.9)                          8728/3

  9530/3              Meningioma, anaplastic                                   9530/3

  \-\-\-\-\-\-\-\--   Metaplastic carcinoma, NOS                               8575/3

  8407/3              Microcystic adnexal carcinoma (C44.\_)                   8407/3

  9594/3              Microglioma (C71.\_) \[obs\]                             9590/3

  8460/3              Micropapillary serous carcinoma (C56.9)                  8460/3

  8154/3              Mixed acinar-endocrine carcinoma (C25.\_)                8154/3

  8244/3              Mixed carcinoid-adenocarcinoma                           8244/3

  8154/3              Mixed ductal-endocrine carcinoma (C25.\_)                8154/3

  8902/3              Mixed embryonal rhabdomyosarcoma and alveolar            8902/3
                      rhabdomyosarcoma                                         

  \-\-\-\-\-\-\-\--   Mixed medullary-follicular carcinoma (C73.9)             8346/3

  \-\-\-\-\-\-\-\--   Mixed medullary-papillary carcinoma (C73.9)              8347/3

  9362/3              Mixed pineal tumor (C75.3)                               9362/3

  9362/3              Mixed pineocytoma-pineoblastoma (C75.3)                  9362/3

  8045/3              Mixed small cell carcinoma                               8045/3

  9085/3              Mixed teratoma and seminoma                              9085/3

  9890/3              Monocytic leukemia, NOS                                  9860/3

  9711/3              Monocytoid B-cell lymphoma                               9699/3

  9481/3              Monstrocellular sarcoma (C71.\_) \[obs\]                 9441/3

  9540/3              MPNST with glandular differentiation                     9540/3

  9540/3              MPNST with mesenchymal differentiation                   9540/3

  9561/3              MPNST with rhabdomyoblastic differentiation              9561/3

  9540/3              MPNST, NOS                                               9540/3

  9762/3              Mu heavy chain disease                                   9762/3

  9015/3              Mucinous adenocarcinofibroma (C56.9)                     9015/3

  \-\-\-\-\-\-\-\--   Mucinous adenocarcinoma, endocervical type               8482/3

  9015/3              Mucinous cystadenocarcinofibroma (C56.9)                 9015/3

  8470/2              Mucinous cystadenocarcinoma, non-invasive (C25.\_)       8470/2

  \-\-\-\-\-\-\-\--   Mucosal lentiginous melanoma                             8746/3

  9715/3 \*           Mucosal-associated lymphoid tissue lymphoma              9699/3

  \-\-\-\-\-\-\-\--   Multifocal superficial basal cell carcinoma (C44.\_)     8091/3

  \-\-\-\-\-\-\-\--   Myelodysplastic syndrome with 5q- syndrome               9986/3

  9961/3              Myelofibrosis as a result of myeloproliferative          9961/3
                      disease                                                  

  9961/1              Myelofibrosis with myeloid metaplasia                    9961/3

  9930/3              Myeloid sarcoma (See also M-9861/3)                      9930/3

  9961/1              Myelosclerosis with myeloid metaplasia                   9961/3

  8982/3              Myoepithelial carcinoma                                  8982/3

  \-\-\-\-\-\-\-\--   NK/T-cell lymphoma, nasal and nasal-type                 9719/3

  \-\-\-\-\-\-\-\--   Nodal marginal zone lymphoma                             9699/3

  8402/3              Nodular hidradenoma, malignant (C44.\_)                  8402/3

  9722/3              Nonlipid reticuloendotheliosis \[obs\]                   9754/3

  9860/3              Non-lymphocytic leukemia, NOS                            9860/3

  \-\-\-\-\-\-\-\--   Non-small cell carcinoma (C34.\_)                        8046/3

  \-\-\-\-\-\-\-\--   Odontogenic carcinosarcoma                               9342/3

  9521/3              Olfactory neurocytoma (C30.0)                            9521/3

  9700/3              Pagetoid reticulosis                                     9700/3

  8260/3              Papillary carcinoma of thyroid (C73.9)                   8260/3

  \-\-\-\-\-\-\-\--   Papillary carcinoma, columnar cell (C73.9)               8344/3

  8350/3              Papillary carcinoma, diffuse sclerosing (C73.9)          8350/3

  \-\-\-\-\-\-\-\--   Papillary carcinoma, encapsulated (C73.9)                8343/3

  \-\-\-\-\-\-\-\--   Papillary carcinoma, oxyphilic cell (C73.9)              8342/3

  \-\-\-\-\-\-\-\--   Papillary carcinoma, tall cell (C73.9)                   8344/3

  9393/1              Papillary ependymoma (C71.\_)                            9393/3

  9538/1              Papillary meningioma                                     9538/3

  \-\-\-\-\-\-\-\--   Papillary microcarcinoma (C73.9)                         8341/3

  8260/3              Papillary renal cell carcinoma (C64.9)                   8260/3

  8052/2              Papillary squamous cell carcinoma in situ                8052/2

  8052/2              Papillary squamous cell carcinoma, non-invasive          8052/2

  8130/2              Papillary transitional cell carcinoma, non-invasive      8130/2
                      (C67.\_)                                                 

  8130/3              Papillary urothelial carcinoma (C67.\_)                  8130/3

  8130/2              Papillary urothelial carcinoma, non-invasive (C67.\_)    8130/2

  8263/3              Papillotubular adenocarcinoma                            8263/3

  8510/3              Parafollicular cell carcinoma (C73.9)                    8345/3

  \-\-\-\-\-\-\-\--   Parietal cell adenocarcinoma (C16.\_)                    8214/3

  \-\-\-\-\-\-\-\--   Parietal cell carcinoma (C16.\_)                         8214/3

  9190/3              Parosteal osteosarcoma (C40.\_, C41.\_)                  9192/3

  \-\-\-\-\-\-\-\--   Perineural MPNST                                         9571/3

  \-\-\-\-\-\-\-\--   Perineurioma, malignant                                  9571/3

  9221/3              Periosteal chondrosarcoma (C40.\_, C41.\_)               9221/3

  9190/3              Periosteal osteosarcoma (C40.\_, C41.\_)                 9193/3

  9364/3              Peripheral primitive neuroectodermal tumor, NOS          9364/3

  9702/3              Peripheral T-cell lymphoma, large cell                   9702/3

  9707/3              Peripheral T-cell lymphoma, pleomorphic medium and       9702/3
                      large cell                                               

  9706/3              Peripheral T-cell lymphoma, pleomorphic small cell       9702/3

  9421/3              Pilocytic astrocytoma (C71.\_)                           9421/1

  9421/3              Piloid astrocytoma (C71.\_)                              9421/1

  8110/3              Pilomatricoma, malignant (C44.\_)                        8110/3

  9362/3              Pineal parenchymal tumor of intermediate                 9362/3
                      differentiation (C75.3)                                  

  8093/3              Pinkus tumor                                             8093/3

  \-\-\-\-\-\-\-\--   Pituitary carcinoma, NOS (C75.1)                         8272/3

  9830/3              Plasma cell leukemia (C42.1)                             9733/3

  9684/3              Plasmablastic lymphoma                                   9684/3

  9830/3              Plasmacytic leukemia (C42.1)                             9733/3

  9731/3              Plasmacytoma of bone (C40.\_, C41.\_)                    9731/3

  9731/3              Plasmacytoma, extramedullary (not occurring in bone)     9734/3

  8901/3              Pleomorphic rhabdomyosarcoma, adult type                 8901/3

  \-\-\-\-\-\-\-\--   Pleuropulmonary blastoma                                 8973/3

  9473/3              PNET, NOS                                                9473/3

  9423/3              Polar spongioblastoma (C71.\_)                           9423/3

  9950/1              Polycythemia rubra vera                                  9950/3

  9950/1              Polycythemia vera                                        9950/3

  9713/3              Polymorphic reticulosis \[obs\]                          9719/3

  \-\-\-\-\-\-\-\--   Polymorphous low grade adenocarcinoma                    8525/3

  \-\-\-\-\-\-\-\--   Porocarcinoma (C44.\_)                                   8409/3

  9364/3              PPNET                                                    9364/3

  \-\-\-\-\-\-\-\--   Pre-B ALL                                                9836/3

  \-\-\-\-\-\-\-\--   Precursor B-cell lymphoblastic leukemia                  9836/3

  \-\-\-\-\-\-\-\--   Precursor B-cell lymphoblastic lymphoma (See also        9728/3
                      M-9836/3)                                                

  \-\-\-\-\-\-\-\--   Precursor cell lymphoblastic leukemia, NOS (See also     9835/3
                      M-9727/3)                                                

  \-\-\-\-\-\-\-\--   Precursor cell lymphoblastic leukemia, not phenotyped    9835/3

  \-\-\-\-\-\-\-\--   Precursor cell lymphoblastic lymphoma, NOS (See also     9727/3
                      M-9835/3)                                                

  \-\-\-\-\-\-\-\--   Precursor T-cell lymphoblastic leukemia                  9837/3

  \-\-\-\-\-\-\-\--   Precursor T-cell lymphoblastic lymphoma (See also        9729/3
                      M-9837/3)                                                

  \-\-\-\-\-\-\-\--   Pre-pre-B ALL                                            9836/3

  \-\-\-\-\-\-\-\--   Pre-T ALL                                                9837/3

  \-\-\-\-\-\-\-\--   Primary cutaneous anaplastic large cell lymphoma         9718/3
                      (C44.\_)                                                 

  \-\-\-\-\-\-\-\--   Primary cutaneous CD30+ large T-cell lymphoma            9718/3
                      (C44.\_)                                                 

  \-\-\-\-\-\-\-\--   Primary cutaneous CD30+ T-cell lymphoproliferative       9718/3
                      disorder (C44.\_)                                        

  8247/3              Primary cutaneous neuroendocrine carcinoma (C44.\_)      8247/3

  \-\-\-\-\-\-\-\--   Primary effusion lymphoma                                9678/3

  9270/3              Primary intraosseous carcinoma                           9270/3

  8461/3              Primary serous papillary carcinoma of peritoneum         8461/3
                      (C48.1)                                                  

  9443/3              Primitive polar spongioblastoma (C71.\_) \[obs\]         9423/3

  \-\-\-\-\-\-\-\--   Pro-B ALL                                                9836/3

  9950/3              Proliferative polycythemia                               9950/3

  \-\-\-\-\-\-\-\--   Prolymphocytic leukemia, B-cell type                     9833/3

  9825/3              Prolymphocytic leukemia, NOS                             9832/3

  \-\-\-\-\-\-\-\--   Prolymphocytic leukemia, T-cell type                     9834/3

  \-\-\-\-\-\-\-\--   Pro-T ALL                                                9837/3

  8480/3              Pseudomyxoma peritonei with unknown primary site         8480/3
                      (C80.9)                                                  

  9983/3              RAEB                                                     9983/3

  9983/3              RAEB I                                                   9983/3

  9983/3              RAEB II                                                  9983/3

  9984/3              RAEB-T                                                   9984/3

  9982/3              RARS                                                     9982/3

  9980/1              Refractory anemia                                        9980/3

  9983/1              Refractory anemia with excess blasts                     9983/3

  9984/1              Refractory anemia with excess blasts in                  9984/3
                      transformation                                           

  9982/1              Refractory anemia with ringed sideroblasts               9982/3

  9982/1              Refractory anemia with sideroblasts                      9982/3

  9981/1              Refractory anemia without sideroblasts                   9980/3

  \-\-\-\-\-\-\-\--   Refractory cytopenia with multilineage dysplasia         9985/3

  \-\-\-\-\-\-\-\--   Renal carcinoma, collecting duct type (C64.9)            8319/3

  \-\-\-\-\-\-\-\--   Renal cell carcinoma, chromophobe cell (C64.9)           8317/3

  \-\-\-\-\-\-\-\--   Renal cell carcinoma, sarcomatoid (C64.9)                8318/3

  \-\-\-\-\-\-\-\--   Renal cell carcinoma, spindle cell (C64.9)               8318/3

  9593/3              Reticulosarcoma, diffuse \[obs\]                         9591/3

  9593/3              Reticulosarcoma, NOS \[obs\]                             9591/3

  9593/3              Reticulum cell sarcoma, diffuse \[obs\]                  9591/3

  9593/3              Reticulum cell sarcoma, NOS \[obs\]                      9591/3

  \-\-\-\-\-\-\-\--   Retinoblastoma, diffuse (C69.2)                          9513/3

  \-\-\-\-\-\-\-\--   Rhabdoid meningioma                                      9538/3

  8963/3              Rhabdoid tumor, NOS                                      8963/3

  \-\-\-\-\-\-\-\--   Rhabdomyosarcoma with ganglionic differentiation         8921/3

  9185/3              Round cell osteosarcoma (C40.\_, C41.\_)                 9185/3

  \-\-\-\-\-\-\-\--   SALT lymphoma                                            9699/3

  8033/3              Sarcomatoid carcinoma                                    8033/3

  9051/3              Sarcomatoid mesothelioma                                 9051/3

  8851/3              Sclerosing liposarcoma                                   8851/3

  \-\-\-\-\-\-\-\--   Sclerosing hepatic carcinoma (C22.0)                     8172/3

  8407/3              Sclerosing sweat duct carcinoma (C44.\_)                 8407/3

  9062/3              Seminoma with high mitotic index (C62.\_)                9062/3

  8241/3              Serotonin producing carcinoid                            8241/3

  9014/3              Serous adenocarcinofibroma (C56.9)                       9014/3

  8441/3              Serous carcinoma, NOS                                    8441/3

  9014/3              Serous cystadenocarcinofibroma (C56.9)                   9014/3

  8631/3              Sertoli-Leydig cell tumor, poorly differentiated         8631/3

  \-\-\-\-\-\-\-\--   Sertoli-Leydig cell tumor, poorly differentiated,        8634/3
                      with heterologous elements                               

  8631/3              Sertoli-Leydig cell tumor, sarcomatoid                   8631/3

  \-\-\-\-\-\-\-\--   SETTLE                                                   8588/3

  \-\-\-\-\-\-\-\--   Skin-associated lymphoid tissue lymphoma                 9699/3

  8041/3              Small cell neuroendocrine carcinoma                      8041/3

  8230/3              Solid adenocarcinoma with mucin formation                8230/3

  8230/3              Solid carcinoma with mucin formation                     8230/3

  8452/3              Solid pseudopapillary carcinoma (C25.\_)                 8452/3

  \-\-\-\-\-\-\-\--   Solitary fibrous tumor, malignant                        8815/3

  \-\-\-\-\-\-\-\--   Somatostatin cell tumor, malignant                       8156/3

  \-\-\-\-\-\-\-\--   Somatostatinoma, malignant                               8156/3

  \-\-\-\-\-\-\-\--   Spindle cell rhabdomyosarcoma                            8912/3

  \-\-\-\-\-\-\-\--   Spindle epithelial tumor with thymus-like                8588/3
                      differentiation                                          

  \-\-\-\-\-\-\-\--   Spindle epithelial tumor with thymus-like element        8588/3

  9051/3              Spindled mesothelioma                                    9051/3

  \-\-\-\-\-\-\-\--   Splenic lymphoma with villous lymphocytes (C42.2)        9689/3

  \-\-\-\-\-\-\-\--   Splenic marginal zone B-cell lymphoma (C42.2)            9689/3

  \-\-\-\-\-\-\-\--   Splenic marginal zone lymphoma, NOS (C42.2)              9689/3

  \-\-\-\-\-\-\-\--   Squamous cell carcinoma with horn formation              8078/3

  8075/3              Squamous cell carcinoma, acantholytic                    8075/3

  \-\-\-\-\-\-\-\--   Squamous cell carcinoma, clear cell type                 8084/3

  8074/3              Squamous cell carcinoma, sarcomatoid                     8074/3

  8077/2              Squamous intraepithelial neoplasia, grade III            8077/2

  9801/3              Stem cell leukemia                                       9801/3

  8670/3              Steroid cell tumor, malignant                            8670/3

  8931/1              Stromal endometriosis (C54.1)                            8931/3

  8931/1              Stromal myosis, NOS (C54.1)                              8931/3

  8930/3              Stromal sarcoma, NOS                                     8935/3

  9862/3              Subacute granulocytic leukemia \[obs\]                   9860/3

  9802/3              Subacute leukemia, NOS \[obs\]                           9800/3

  9822/3              Subacute lymphatic leukemia \[obs\]                      9820/3

  9822/3              Subacute lymphocytic leukemia \[obs\]                    9820/3

  9822/3              Subacute lymphoid leukemia \[obs\]                       9820/3

  9892/3              Subacute monocytic leukemia \[obs\]                      9860/3

  9862/3              Subacute myelogenous leukemia \[obs\]                    9860/3

  9862/3              Subacute myeloid leukemia \[obs\]                        9860/3

  \-\-\-\-\-\-\-\--   Subcutaneous panniculitis-like T-cell lymphoma           9708/3

  9473/3              Supratentorial PNET (C71.\_)                             9473/3

  9041/3              Synovial sarcoma, monophasic fibrous                     9041/3

  8407/3              Syringomatous carcinoma (C44.\_)                         8407/3

  \-\-\-\-\-\-\-\--   T/NK-cell lymphoma                                       9719/3

  9391/3              Tanycytic ependymoma (C71.\_)                            9391/3

  9702/3              T-cell lymphoma, NOS                                     9702/3

  9688/3 \*           T-cell rich large B-cell lymphoma                        9680/3

  9680/3              T-cell rich/histiocyte-rich large B-cell lymphoma        9680/3

  \-\-\-\-\-\-\-\--   Terminal duct adenocarcinoma                             8525/3

  \-\-\-\-\-\-\-\--   Therapy-related acute myeloid leukemia and               9920/3
                      myelodysplastic syndrome, NOS                            

  \-\-\-\-\-\-\-\--   Therapy-related acute myeloid leukemia, alkylating       9920/3
                      agent related                                            

  \-\-\-\-\-\-\-\--   Therapy-related acute myeloid leukemia,                  9920/3
                      epipodophyllotoxin-related                               

  \-\-\-\-\-\-\-\--   Therapy-related myelodysplastic syndrome, alkylating     9987/3
                      agent related                                            

  \-\-\-\-\-\-\-\--   Therapy-related myelodysplastic syndrome,                9987/3
                      epidopophyllotoxin-related                               

  \-\-\-\-\-\-\-\--   Therapy-related myelodysplastic syndrome, NOS            9987/3

  8580/3              Thymic carcinoma (C37.9)                                 8586/3

  \-\-\-\-\-\-\-\--   Thymic large B-cell lymphoma (C37.9)                     9679/3

  \-\-\-\-\-\-\-\--   Thymoma, atypical, malignant (C37.9)                     8585/3

  \-\-\-\-\-\-\-\--   Thymoma, cortical, malignant (C37.9)                     8584/3

  \-\-\-\-\-\-\-\--   Thymoma, epithelial, malignant (C37.9)                   8585/3

  \-\-\-\-\-\-\-\--   Thymoma, lymphocyte-rich, malignant (C37.9)              8583/3

  \-\-\-\-\-\-\-\--   Thymoma, lymphocytic, malignant (C37.9)                  8583/3

  \-\-\-\-\-\-\-\--   Thymoma, medullary, malignant (C37.9)                    8581/3

  \-\-\-\-\-\-\-\--   Thymoma, mixed type, malignant (C37.9)                   8582/3

  \-\-\-\-\-\-\-\--   Thymoma, organoid, malignant (C37.9)                     8583/3

  \-\-\-\-\-\-\-\--   Thymoma, predominantly cortical, malignant (C37.9)       8583/3

  \-\-\-\-\-\-\-\--   Thymoma, spindle cell, malignant (C37.9)                 8581/3

  \-\-\-\-\-\-\-\--   Thymoma, type A, malignant (C37.9)                       8581/3

  \-\-\-\-\-\-\-\--   Thymoma, type AB, malignant (C37.9)                      8582/3

  \-\-\-\-\-\-\-\--   Thymoma, type B1, malignant (C37.9)                      8583/3

  \-\-\-\-\-\-\-\--   Thymoma, type B2, malignant (C37.9)                      8584/3

  \-\-\-\-\-\-\-\--   Thymoma, type B3, malignant (C37.9)                      8585/3

  \-\-\-\-\-\-\-\--   Thymoma, type C (C37.9)                                  8586/3

  \-\-\-\-\-\-\-\--   Transitional cell carcinoma, micropapillary (C67.\_)     8131/3

  8122/3              Transitional cell carcinoma, sarcomatoid                 8122/3

  9362/3              Transitional pineal tumor (C75.3)                        9362/3

  8102/3              Trichilemmal carcinoma (C44.\_)                          8102/3

  8102/3              Trichilemmocarcinoma (C44.\_)                            8102/3

  \-\-\-\-\-\-\-\--   Trophoblastic tumor, epithelioid                         9105/3

  9723/3              True histiocytic lymphoma \[obs\]                        9755/3

  8263/3              Tubulopapillary adenocarcinoma                           8263/3

  8240/3              Typical carcinoid                                        8240/3

  9703/3              T-zone lymphoma                                          9702/3

  \-\-\-\-\-\-\-\--   Undifferentiated sarcoma                                 8805/3

  8120/2              Urothelial carcinoma in situ                             8120/2

  8077/2              Vaginal intraepithelial neoplasia, grade III (C52.\_)    8077/2

  8155/3              Vipoma, malignant                                        8155/3

  8077/2              Vulvar intraepithelial neoplasia, grade III (C51.\_)     8077/2

  8051/3              Warty carcinoma                                          8051/3

  \-\-\-\-\-\-\-\--   Well differentiated thymic carcinoma (C37.9)             8585/3
  ------------------- ----------------------------------------------------- -- -------------

  ------------------- ---------------------------------------------------- --- -------------
                      **NUMERIC SORT ON ICD-O-3**                              

                                                                               

                      **Containing:**                                          

                      **NEW ICD-O-3 CODES**                                    

                      **NEW MORPHOLOGY TERMS AND SYNONYMS**                    

                      **TERMS THAT CHANGED FROM BORDERLINE TO MALIGNANT**      

                      **TERMS THAT CHANGED MORPHOLOGY CODE**                   

                      **TERMS THAT CHANGED FROM TUMOR-LIKE LESIONS TO          
                      NEOPLASMS**                                              

                                                                               

                                                                               

                      **Key:**                                                 

                      \* code used in United States (1995-2000) and in         
                      Canada (1997-2000)                                       

                      \*\* code used in United States and Canada               
                      (1998-2000)                                              

                      \-\-\-\-\-\-\-\-- code did (does) not exist              

                      [Note]{.underline}: Code 9421/1: Juvenile                
                      astrocytoma, pilocytic astrocytoma, and piloid           
                      astrocytoma is reportable as 9421/[3]{.underline}        
                      for cases diagnosed 2001 and after.                      

                      Code 8148/2, however, is not reportable: Glandular       
                      intraepithelial neoplasia, grade III.                    

                      Prostatic intraepithelial neoplasia, grade III; &        
                      PIN III. These terms are not included in this list.      

                                                                               

  **ICD-O-2**         **Term as it appears in ICD-O-3**                        **ICD-O-3**

  \-\-\-\-\-\-\-\--   Malignant tumor, clear cell type                         8005/3

  \-\-\-\-\-\-\-\--   Large cell neuroendocrine carcinoma                      8013/3

  \-\-\-\-\-\-\-\--   Large cell carcinoma with rhabdoid phenotype             8014/3

  \-\-\-\-\-\-\-\--   Glassy cell carcinoma                                    8015/3

  8033/3              Sarcomatoid carcinoma                                    8033/3

  \-\-\-\-\-\-\-\--   Carcinoma with osteoclast-like giant cells               8035/3

  8041/3              Small cell neuroendocrine carcinoma                      8041/3

  8045/3              Combined small cell carcinoma                            8045/3

  8045/3              Combined small cell-adenocarcinoma                       8045/3

  8045/3              Combined small cell-squamous cell carcinoma              8045/3

  8045/3              Mixed small cell carcinoma                               8045/3

  \-\-\-\-\-\-\-\--   Non-small cell carcinoma (C34.\_)                        8046/3

  8051/3              Condylomatous carcinoma                                  8051/3

  8051/3              Warty carcinoma                                          8051/3

  8052/2              Papillary squamous cell carcinoma in situ                8052/2

  8052/2              Papillary squamous cell carcinoma, non-invasive          8052/2

  8074/3              Squamous cell carcinoma, sarcomatoid                     8074/3

  8075/3              Squamous cell carcinoma, acantholytic                    8075/3

  8077/2              AIN III (C21.1)                                          8077/2

  8077/2              Anal intraepithelial neoplasia (C21.1)                   8077/2

  8077/2              Squamous intraepithelial neoplasia, grade III            8077/2

  8077/2              Vaginal intraepithelial neoplasia, grade III             8077/2
                      (C52.\_)                                                 

  8077/2              Vulvar intraepithelial neoplasia, grade III (C51.\_)     8077/2

  \-\-\-\-\-\-\-\--   Squamous cell carcinoma with horn formation              8078/3

  8082/3              Lymphoepithelioma-like carcinoma                         8082/3

  \-\-\-\-\-\-\-\--   Basaloid squamous cell carcinoma                         8083/3

  \-\-\-\-\-\-\-\--   Squamous cell carcinoma, clear cell type                 8084/3

  8091/3              Multifocal superficial basal cell carcinoma (C44.\_)     8091/3

  8092/3              Basal cell carcinoma, desmoplastic type (C44.\_)         8092/3

  8092/3              Basal cell carcinoma, morpheic (C44.\_)                  8092/3

  8092/3              Infiltrating basal cell carcinoma, non-sclerosing        8092/3
                      (C44.\_)                                                 

  8092/3              Infiltrating basal cell carcinoma, NOS (C44.\_)          8092/3

  8092/3              Infiltrating basal cell carcinoma, sclerosing            8092/3
                      (C44.\_)                                                 

  8093/3              Fibroepithelial basal cell carcinoma, Pinkus type        8093/3

  8093/3              Fibroepithelioma of Pinkus type                          8093/3

  8093/3              Fibroepithelioma, NOS                                    8093/3

  8093/3              Pinkus tumor                                             8093/3

  \-\-\-\-\-\-\-\--   Basal cell carcinoma, micronodular (C44.\_)              8097/3

  \-\-\-\-\-\-\-\--   Basal cell carcinoma, nodular (C44.\_)                   8097/3

  \-\-\-\-\-\-\-\--   Adenoid basal carcinoma (C53.\_)                         8098/3

  8102/3              Trichilemmal carcinoma (C44.\_)                          8102/3

  8102/3              Trichilemmocarcinoma (C44.\_)                            8102/3

  8110/3              Matrical carcinoma (C44.\_)                              8110/3

  8110/3              Pilomatricoma, malignant (C44.\_)                        8110/3

  8120/2              Urothelial carcinoma in situ                             8120/2

  8121/3              Cylindrical cell carcinoma (C30.0, C31.\_)               8121/3

  8122/3              Transitional cell carcinoma, sarcomatoid                 8122/3

  8130/2              Papillary transitional cell carcinoma, non-invasive      8130/2
                      (C67.\_)                                                 

  8130/2              Papillary urothelial carcinoma, non-invasive             8130/2
                      (C67.\_)                                                 

  8130/3              Papillary urothelial carcinoma (C67.\_)                  8130/3

  \-\-\-\-\-\-\-\--   Transitional cell carcinoma, micropapillary (C67.\_)     8131/3

  8153/3              Gastrin cell tumor, malignant                            8153/3

  8154/3              Mixed acinar-endocrine carcinoma (C25.\_)                8154/3

  8154/3              Mixed ductal-endocrine carcinoma (C25.\_)                8154/3

  8155/3              Vipoma, malignant                                        8155/3

  \-\-\-\-\-\-\-\--   Somatostatin cell tumor, malignant                       8156/3

  \-\-\-\-\-\-\-\--   Somatostatinoma, malignant                               8156/3

  \-\-\-\-\-\-\-\--   Enteroglucagonoma, malignant                             8157/3

  \-\-\-\-\-\-\-\--   Hepatocellular carcinoma, scirrhous (C22.0)              8172/3

  \-\-\-\-\-\-\-\--   Sclerosing hepatic carcinoma (C22.0)                     8172/3

  \-\-\-\-\-\-\-\--   Hepatocellular carcinoma, sarcomatoid (C22.0)            8173/3

  \-\-\-\-\-\-\-\--   Hepatocellular carcinoma, spindle cell variant           8173/3
                      (C22.0)                                                  

  \-\-\-\-\-\-\-\--   Hepatocellular carcinoma, clear cell type (C22.0)        8174/3

  \-\-\-\-\-\-\-\--   Hepatocellular carcinoma, pleomorphic type (C22.0)       8175/3

  8201/2              Ductal carcinoma in situ, cribriform type (C50.\_)       8201/2

  8201/3              Ductal carcinoma, cribriform type (C50.\_)               8201/3

  \-\-\-\-\-\-\-\--   Parietal cell adenocarcinoma (C16.\_)                    8214/3

  \-\-\-\-\-\-\-\--   Parietal cell carcinoma (C16.\_)                         8214/3

  \-\-\-\-\-\-\-\--   Adenocarcinoma of anal ducts (C21.1)                     8215/3

  \-\-\-\-\-\-\-\--   Adenocarcinoma of anal glands (C21.1)                    8215/3

  8230/2              Ductal carcinoma in situ, solid type (C50.\_)            8230/2

  8230/2              Intraductal carcinoma, solid type                        8230/2

  8230/3              Solid adenocarcinoma with mucin formation                8230/3

  8230/3              Solid carcinoma with mucin formation                     8230/3

  8240/3              Typical carcinoid                                        8240/3

  8241/3              EC cell carcinoid                                        8241/3

  8241/3              Enterochromaffin cell carcinoid                          8241/3

  8241/3              Serotonin producing carcinoid                            8241/3

  \-\-\-\-\-\-\-\--   ECL cell carcinoid, malignant                            8242/3

  \-\-\-\-\-\-\-\--   Enterochromaffin-like cell tumor, malignant              8242/3

  8244/3              Mixed carcinoid-adenocarcinoma                           8244/3

  8247/3              Primary cutaneous neuroendocrine carcinoma (C44.\_)      8247/3

  \-\-\-\-\-\-\-\--   Atypical carcinoid tumor                                 8249/3

  \-\-\-\-\-\-\-\--   Bronchiolo-alveolar carcinoma, Clara cell (C34.\_)       8252/3

  \-\-\-\-\-\-\-\--   Bronchiolo-alveolar carcinoma, non-mucinous (C34.\_)     8252/3

  \-\-\-\-\-\-\-\--   Bronchiolo-alveolar carcinoma, type II pneumocyte        8252/3
                      (C34.\_)                                                 

  \-\-\-\-\-\-\-\--   Bronchiolo-alveolar carcinoma, goblet cell type          8253/3
                      (C34.\_)                                                 

  \-\-\-\-\-\-\-\--   Bronchiolo-alveolar carcinoma, mucinous (C34.\_)         8253/3

  \-\-\-\-\-\-\-\--   Bronchiolo-alveolar carcinoma, Clara cell and goblet     8254/3
                      cell type (C34.\_)                                       

  \-\-\-\-\-\-\-\--   Bronchiolo-alveolar carcinoma, indeterminate type        8254/3
                      (C34.\_)                                                 

  \-\-\-\-\-\-\-\--   Bronchiolo-alveolar carcinoma, mixed mucinous and        8254/3
                      non-mucinous (C34.\_)                                    

  \-\-\-\-\-\-\-\--   Bronchiolo-alveolar carcinoma, type II pneumocyte        8254/3
                      and goblet cell type (C34.\_)                            

  \-\-\-\-\-\-\-\--   Adenocarcinoma combined with other types of              8255/3
                      carcinoma                                                

  \-\-\-\-\-\-\-\--   Adenocarcinoma with mixed subtypes                       8255/3

  8260/3              Papillary carcinoma of thyroid (C73.9)                   8260/3

  8260/3              Papillary renal cell carcinoma (C64.9)                   8260/3

  8263/3              Papillotubular adenocarcinoma                            8263/3

  8263/3              Tubulopapillary adenocarcinoma                           8263/3

  \-\-\-\-\-\-\-\--   Pituitary carcinoma, NOS (C75.1)                         8272/3

  8290/3              Follicular carcinoma, oxyphilic cell (C73.9)             8290/3

  8313/3              Clear cell adenocarcinofibroma (C56.9)                   8313/3

  8313/3              Clear cell cystadenocarcinofibroma (C56.9)               8313/3

  \-\-\-\-\-\-\-\--   Cyst-associated renal cell carcinoma (C64.9)             8316/3

  \-\-\-\-\-\-\-\--   Chromophobe cell renal carcinoma (C64.9)                 8317/3

  \-\-\-\-\-\-\-\--   Renal cell carcinoma, chromophobe cell (C64.9)           8317/3

  \-\-\-\-\-\-\-\--   Renal cell carcinoma, sarcomatoid (C64.9)                8318/3

  \-\-\-\-\-\-\-\--   Renal cell carcinoma, spindle cell (C64.9)               8318/3

  \-\-\-\-\-\-\-\--   Bellini duct carcinoma (C64.9)                           8319/3

  \-\-\-\-\-\-\-\--   Collecting duct carcinoma (C64.9)                        8319/3

  \-\-\-\-\-\-\-\--   Renal carcinoma, collecting duct type (C64.9)            8319/3

  8333/3              Fetal adenocarcinoma                                     8333/3

  \-\-\-\-\-\-\-\--   Follicular carcinoma, encapsulated (C73.9)               8335/3

  \-\-\-\-\-\-\-\--   Follicular carcinoma, minimally invasive (C73.9)         8335/3

  \-\-\-\-\-\-\-\--   Insular carcinoma (C73.9)                                8337/3

  \-\-\-\-\-\-\-\--   Papillary microcarcinoma (C73.9)                         8341/3

  \-\-\-\-\-\-\-\--   Papillary carcinoma, oxyphilic cell (C73.9)              8342/3

  \-\-\-\-\-\-\-\--   Papillary carcinoma, encapsulated (C73.9)                8343/3

  \-\-\-\-\-\-\-\--   Papillary carcinoma, columnar cell (C73.9)               8344/3

  \-\-\-\-\-\-\-\--   Papillary carcinoma, tall cell (C73.9)                   8344/3

  8510/3              C cell carcinoma (C73.9)                                 8345/3

  8511/3              Medullary carcinoma with amyloid stroma (C73.9)          8345/3

  8510/3              Parafollicular cell carcinoma (C73.9)                    8345/3

  \-\-\-\-\-\-\-\--   Mixed medullary-follicular carcinoma (C73.9)             8346/3

  \-\-\-\-\-\-\-\--   Mixed medullary-papillary carcinoma (C73.9)              8347/3

  8350/3              Papillary carcinoma, diffuse sclerosing (C73.9)          8350/3

  \-\-\-\-\-\-\-\--   Endometrioid adenocarcinoma, secretory variant           8382/3
                      (C56.9)                                                  

  \-\-\-\-\-\-\-\--   Endometrioid adenocarcinoma, ciliated cell variant       8383/3

  \-\-\-\-\-\-\-\--   Adenocarcinoma, endocervical type                        8384/3

  8402/3              Hidradenocarcinoma (C44.\_)                              8402/3

  8402/3              Nodular hidradenoma, malignant (C44.\_)                  8402/3

  8403/3              Malignant eccrine spiradenoma (C44.\_)                   8403/3

  8407/3              Microcystic adnexal carcinoma (C44.\_)                   8407/3

  8407/3              Sclerosing sweat duct carcinoma (C44.\_)                 8407/3

  8407/3              Syringomatous carcinoma (C44.\_)                         8407/3

  8408/3              Digital papillary adenocarcinoma (C44.\_)                8408/3

  8408/3              Eccrine papillary adenocarcinoma (C44.\_)                8408/3

  \-\-\-\-\-\-\-\--   Eccrine poroma, malignant                                8409/3

  \-\-\-\-\-\-\-\--   Porocarcinoma (C44.\_)                                   8409/3

  \-\-\-\-\-\-\-\--   Eccrine adenocarcinoma (C44.\_)                          8413/3

  8441/3              Serous carcinoma, NOS                                    8441/3

  8452/3              Solid pseudopapillary carcinoma (C25.\_)                 8452/3

  \-\-\-\-\-\-\-\--   Intraductal papillary-mucinous carcinoma,                8453/2
                      non-invasive (C25.\_)                                    

  \-\-\-\-\-\-\-\--   Intraductal papillary-mucinous carcinoma, invasive       8453/3
                      (C25.\_)                                                 

  8460/3              Micropapillary serous carcinoma (C56.9)                  8460/3

  8461/3              Primary serous papillary carcinoma of peritoneum         8461/3
                      (C48.1)                                                  

  8470/2              Mucinous cystadenocarcinoma, non-invasive (C25.\_)       8470/2

  8480/3              Pseudomyxoma peritonei with unknown primary site         8480/3
                      (C80.9)                                                  

  \-\-\-\-\-\-\-\--   Mucinous adenocarcinoma, endocervical type               8482/3

  8500/2              DCIS, NOS (C50.\_)                                       8500/2

  8500/2              DIN 3 (C50.\_)                                           8500/2

  8500/2              Ductal carcinoma in situ, NOS (C50.\_)                   8500/2

  8500/2              Ductal intraepithelial neoplasia 3 (C50.\_)              8500/2

  8501/2              DCIS, comedo type (C50.\_)                               8501/2

  8501/2              Ductal carcinoma in situ, comedo type (C50.\_)           8501/2

  8503/2              DCIS, papillary (C50.\_)                                 8503/2

  8503/2              Ductal carcinoma in situ, papillary (C50.\_)             8503/2

  8503/3              Infiltrating papillary adenocarcinoma                    8503/3

  \-\-\-\-\-\-\-\--   Ductal carcinoma in situ, micropapillary (C50.\_)        8507/2

  \-\-\-\-\-\-\-\--   Intraductal carcinoma, clinging (C50.\_)                 8507/2

  \-\-\-\-\-\-\-\--   Intraductal micropapillary carcinoma (C50.\_)            8507/2

  \-\-\-\-\-\-\-\--   Cystic hypersecretory carcinoma (C50.\_)                 8508/3

  \-\-\-\-\-\-\-\--   Atypical medullary carcinoma (C50.\_)                    8513/3

  \-\-\-\-\-\-\-\--   Duct carcinoma, desmoplastic type                        8514/3

  8520/2              LCIS, NOS (C50.\_)                                       8520/2

  8522/3              Infiltrating lobular carcinoma and ductal carcinoma      8522/3
                      in situ (C50.\_)                                         

  \-\-\-\-\-\-\-\--   Infiltrating duct and colloid carcinoma (C50.\_)         8523/3

  \-\-\-\-\-\-\-\--   Infiltrating duct and cribriform carcinoma (C50.\_)      8523/3

  \-\-\-\-\-\-\-\--   Infiltrating duct and mucinous carcinoma (C50.\_)        8523/3

  \-\-\-\-\-\-\-\--   Infiltrating duct and tubular carcinoma (C50.\_)         8523/3

  \-\-\-\-\-\-\-\--   Infiltrating duct mixed with other types of              8523/3
                      carcinoma (C50.\_)                                       

  \-\-\-\-\-\-\-\--   Infiltrating lobular mixed with other types of           8524/3
                      carcinoma (C50.\_)                                       

  \-\-\-\-\-\-\-\--   Polymorphous low grade adenocarcinoma                    8525/3

  \-\-\-\-\-\-\-\--   Terminal duct adenocarcinoma                             8525/3

  \-\-\-\-\-\-\-\--   Acinar cell cystadenocarcinoma                           8551/3

  \-\-\-\-\-\-\-\--   Adenocarcinoma with neuroendocrine differentiation       8574/3

  \-\-\-\-\-\-\-\--   Carcinoma with neuroendocrine differentiation            8574/3

  \-\-\-\-\-\-\-\--   Metaplastic carcinoma, NOS                               8575/3

  \-\-\-\-\-\-\-\--   Hepatoid adenocarcinoma                                  8576/3

  \-\-\-\-\-\-\-\--   Hepatoid carcinoma                                       8576/3

  \-\-\-\-\-\-\-\--   Thymoma, medullary, malignant (C37.9)                    8581/3

  \-\-\-\-\-\-\-\--   Thymoma, spindle cell, malignant (C37.9)                 8581/3

  \-\-\-\-\-\-\-\--   Thymoma, type A, malignant (C37.9)                       8581/3

  \-\-\-\-\-\-\-\--   Thymoma, mixed type, malignant (C37.9)                   8582/3

  \-\-\-\-\-\-\-\--   Thymoma, type AB, malignant (C37.9)                      8582/3

  \-\-\-\-\-\-\-\--   Thymoma, lymphocyte-rich, malignant (C37.9)              8583/3

  \-\-\-\-\-\-\-\--   Thymoma, lymphocytic, malignant (C37.9)                  8583/3

  \-\-\-\-\-\-\-\--   Thymoma, organoid, malignant (C37.9)                     8583/3

  \-\-\-\-\-\-\-\--   Thymoma, predominantly cortical, malignant (C37.9)       8583/3

  \-\-\-\-\-\-\-\--   Thymoma, type B1, malignant (C37.9)                      8583/3

  \-\-\-\-\-\-\-\--   Thymoma, cortical, malignant (C37.9)                     8584/3

  \-\-\-\-\-\-\-\--   Thymoma, type B2, malignant (C37.9)                      8584/3

  \-\-\-\-\-\-\-\--   Thymoma, atypical, malignant (C37.9)                     8585/3

  \-\-\-\-\-\-\-\--   Thymoma, epithelial, malignant (C37.9)                   8585/3

  \-\-\-\-\-\-\-\--   Thymoma, type B3, malignant (C37.9)                      8585/3

  \-\-\-\-\-\-\-\--   Well differentiated thymic carcinoma (C37.9)             8585/3

  8580/3              Thymic carcinoma (C37.9)                                 8586/3

  \-\-\-\-\-\-\-\--   Thymoma, type C (C37.9)                                  8586/3

  \-\-\-\-\-\-\-\--   SETTLE                                                   8588/3

  \-\-\-\-\-\-\-\--   Spindle epithelial tumor with thymus-like                8588/3
                      differentiation                                          

  \-\-\-\-\-\-\-\--   Spindle epithelial tumor with thymus-like element        8588/3

  \-\-\-\-\-\-\-\--   Carcinoma showing thymus-like differentiation            8589/3

  \-\-\-\-\-\-\-\--   Carcinoma showing thymus-like element                    8589/3

  \-\-\-\-\-\-\-\--   CASTLE                                                   8589/3

  8620/3              Granulosa cell tumor, sarcomatoid (C56.9)                8620/3

  8631/3              Sertoli-Leydig cell tumor, poorly differentiated         8631/3

  8631/3              Sertoli-Leydig cell tumor, sarcomatoid                   8631/3

  \-\-\-\-\-\-\-\--   Sertoli-Leydig cell tumor, poorly differentiated,        8634/3
                      with heterologous elements                               

  8670/3              Steroid cell tumor, malignant                            8670/3

  8700/3              Adrenal medullary paraganglioma, malignant (C74.1)       8700/3

  8711/3              Glomus tumor, malignant                                  8711/3

  \-\-\-\-\-\-\-\--   Meningeal melanomatosis (C70.9)                          8728/3

  8745/3              Desmoplastic melanoma, amelanotic (C44.\_)               8745/3

  \-\-\-\-\-\-\-\--   Mucosal lentiginous melanoma                             8746/3

  8761/3              Malignant melanoma in congenital melanocytic nevus       8761/3
                      (C44.\_)                                                 

  \-\-\-\-\-\-\-\--   Undifferentiated sarcoma                                 8805/3

  \-\-\-\-\-\-\-\--   Desmoplastic small round cell tumor                      8806/3

  \-\-\-\-\-\-\-\--   Solitary fibrous tumor, malignant                        8815/3

  8851/3              Inflammatory liposarcoma                                 8851/3

  8851/3              Lipoma-like liposarcoma                                  8851/3

  8851/3              Sclerosing liposarcoma                                   8851/3

  8857/3              Fibroblastic liposarcoma                                 8857/3

  8901/3              Pleomorphic rhabdomyosarcoma, adult type                 8901/3

  8902/3              Mixed embryonal rhabdomyosarcoma and alveolar            8902/3
                      rhabdomyosarcoma                                         

  8910/3              Embryonal rhabdomyosarcoma, pleomorphic                  8910/3

  \-\-\-\-\-\-\-\--   Spindle cell rhabdomyosarcoma                            8912/3

  \-\-\-\-\-\-\-\--   Ectomesenchymoma                                         8921/3

  \-\-\-\-\-\-\-\--   Rhabdomyosarcoma with ganglionic differentiation         8921/3

  8930/3              Endometrial stromal sarcoma, high grade (C54.1)          8930/3

  8931/1              Endolymphatic stromal myosis (C54.1)                     8931/3

  8931/1              Endometrial stromal sarcoma, low grade (C54.1)           8931/3

  8931/1              Endometrial stromatosis (C54.1)                          8931/3

  8931/1              Stromal endometriosis (C54.1)                            8931/3

  8931/1              Stromal myosis, NOS (C54.1)                              8931/3

  \-\-\-\-\-\-\-\--   Carcinofibroma                                           8934/3

  8930/3              Stromal sarcoma, NOS                                     8935/3

  \-\-\-\-\-\-\-\--   Gastrointestinal stromal sarcoma                         8936/3

  \-\-\-\-\-\-\-\--   Gastrointestinal stromal tumor, malignant                8936/3

  \-\-\-\-\-\-\-\--   GIST, malignant                                          8936/3

  8940/3              Malignant chondroid syringoma (C44.\_)                   8940/3

  \-\-\-\-\-\-\-\--   Malignant cystic nephroma (C64.9)                        8959/3

  \-\-\-\-\-\-\-\--   Malignant multilocular cystic nephroma (C64.9)           8959/3

  8963/3              Malignant rhabdoid tumor                                 8963/3

  8963/3              Rhabdoid tumor, NOS                                      8963/3

  \-\-\-\-\-\-\-\--   Pleuropulmonary blastoma                                 8973/3

  8982/3              Malignant myoepithelioma                                 8982/3

  8982/3              Myoepithelial carcinoma                                  8982/3

  9014/3              Malignant serous adenofibroma (C56.9)                    9014/3

  9014/3              Malignant serous cystadenofibroma (C56.9)                9014/3

  9014/3              Serous adenocarcinofibroma (C56.9)                       9014/3

  9014/3              Serous cystadenocarcinofibroma (C56.9)                   9014/3

  9015/3              Malignant mucinous adenofibroma (C56.9)                  9015/3

  9015/3              Malignant mucinous cystadenofibroma (C56.9)              9015/3

  9015/3              Mucinous adenocarcinofibroma (C56.9)                     9015/3

  9015/3              Mucinous cystadenocarcinofibroma (C56.9)                 9015/3

  9041/3              Synovial sarcoma, monophasic fibrous                     9041/3

  9051/3              Desmoplastic mesothelioma                                9051/3

  9051/3              Sarcomatoid mesothelioma                                 9051/3

  9051/3              Spindled mesothelioma                                    9051/3

  9062/3              Seminoma with high mitotic index (C62.\_)                9062/3

  9064/2              Intratubular germ cell neoplasia (C62.\_)                9064/2

  9064/2              Intratubular malignant germ cells (C62.\_)               9064/2

  \-\-\-\-\-\-\-\--   Germ cell tumor, nonseminomatous (C62.\_)                9065/3

  9071/3              Hepatoid yolk sac tumor                                  9071/3

  9080/3              Immature teratoma, malignant                             9080/3

  9084/3              Dermoid cyst with secondary tumor                        9084/3

  9085/3              Mixed teratoma and seminoma                              9085/3

  \-\-\-\-\-\-\-\--   Trophoblastic tumor, epithelioid                         9105/3

  9134/1              Intravascular bronchial alveolar tumor (C34.\_)          9133/3
                      \[obs\]                                                  

  9185/3              Round cell osteosarcoma (C40.\_, C41.\_)                 9185/3

  \-\-\-\-\-\-\-\--   Central osteosarcoma (C40.\_, C41.\_)                    9186/3

  \-\-\-\-\-\-\-\--   Conventional central osteosarcoma (C40.\_, C41.\_)       9186/3

  \-\-\-\-\-\-\-\--   Medullary osteosarcoma (C40.\_, C41.\_)                  9186/3

  \-\-\-\-\-\-\-\--   Intraosseous low grade osteosarcoma (C40.\_, C41.\_)     9187/3

  \-\-\-\-\-\-\-\--   Intraosseous well differentiated osteosarcoma            9187/3
                      (C40.\_, C41.\_)                                         

  9190/3              Juxtacortical osteosarcoma (C40.\_, C41.\_)              9192/3

  9190/3              Parosteal osteosarcoma (C40.\_, C41.\_)                  9192/3

  9190/3              Periosteal osteosarcoma (C40.\_, C41.\_)                 9193/3

  \-\-\-\-\-\-\-\--   High grade surface osteosarcoma (C40.\_, C41.\_)         9194/3

  \-\-\-\-\-\-\-\--   Intracortical osteosarcoma (C40.\_, C41.\_)              9195/3

  9221/3              Periosteal chondrosarcoma (C40.\_, C41.\_)               9221/3

  \-\-\-\-\-\-\-\--   Clear cell chondrosarcoma (C40.\_, C41.\_)               9242/3

  \-\-\-\-\-\-\-\--   Dedifferentiated chondrosarcoma (C40.\_, C41.\_)         9243/3

  \-\-\-\-\-\-\-\--   Giant cell tumor of tendon sheath, malignant             9252/3
                      (C49.\_)                                                 

  \-\-\-\-\-\-\-\--   Malignant tenosynovial giant cell tumor (C49.\_)         9252/3

  9270/3              Primary intraosseous carcinoma                           9270/3

  9290/3              Ameloblastic fibrodentinosarcoma                         9290/3

  9290/3              Ameloblastic fibro-odontosarcoma                         9290/3

  \-\-\-\-\-\-\-\--   Odontogenic carcinosarcoma                               9342/3

  9362/3              Mixed pineal tumor (C75.3)                               9362/3

  9362/3              Mixed pineocytoma-pineoblastoma (C75.3)                  9362/3

  9362/3              Pineal parenchymal tumor of intermediate                 9362/3
                      differentiation (C75.3)                                  

  9362/3              Transitional pineal tumor (C75.3)                        9362/3

  9364/3              Peripheral primitive neuroectodermal tumor, NOS          9364/3

  9364/3              PPNET                                                    9364/3

  8803/3              Askin tumor                                              9365/3

  \-\-\-\-\-\-\-\--   Chondroid chordoma                                       9371/3

  \-\-\-\-\-\-\-\--   Dedifferentiated chordoma                                9372/3

  9382/3              Anaplastic oligoastrocytoma (C71.\_)                     9382/3

  9390/3              Choroid plexus carcinoma (C71.5)                         9390/3

  9391/3              Cellular ependymoma (C71.\_)                             9391/3

  9391/3              Clear cell ependymoma (C71.\_)                           9391/3

  9391/3              Tanycytic ependymoma (C71.\_)                            9391/3

  9393/1              Papillary ependymoma (C71.\_)                            9393/3

  9400/3              Astrocytoma, low grade (C71.\_)                          9400/3

  9400/3              Diffuse astrocytoma (C71.\_)                             9400/3

  9400/3              Diffuse astrocytoma, low grade (C71.\_)                  9400/3

  9421/3              Juvenile astrocytoma (C71.\_)                            9421/1

  9421/3              Pilocytic astrocytoma (C71.\_)                           9421/1

  9421/3              Piloid astrocytoma (C71.\_)                              9421/1

  9423/3              Polar spongioblastoma (C71.\_)                           9423/3

  9443/3              Primitive polar spongioblastoma (C71.\_) \[obs\]         9423/3

  9481/3              Monstrocellular sarcoma (C71.\_) \[obs\]                 9441/3

  9470/3              Melanotic medulloblastoma (C71.6)                        9470/3

  9471/3              Desmoplastic nodular medulloblastoma (C71.6)             9471/3

  9473/3              Central primitive neuroectodermal tumor, NOS             9473/3
                      (C71.\_)                                                 

  9473/3              CPNET (C71.\_)                                           9473/3

  9473/3              PNET, NOS                                                9473/3

  9473/3              Supratentorial PNET (C71.\_)                             9473/3

  \-\-\-\-\-\-\-\--   Large cell medulloblastoma (C71.6)                       9474/3

  9500/3              Central neuroblastoma (C71.\_)                           9500/3

  9501/3              Diktyoma, malignant (C69.\_)                             9501/3

  9505/3              Ganglioglioma, anaplastic                                9505/3

  \-\-\-\-\-\-\-\--   Atypical teratoid/rhabdoid tumor (C71.\_)                9508/3

  \-\-\-\-\-\-\-\--   Retinoblastoma, diffuse (C69.2)                          9513/3

  9521/3              Olfactory neurocytoma (C30.0)                            9521/3

  9530/3              Meningioma, anaplastic                                   9530/3

  9538/1              Papillary meningioma                                     9538/3

  9538/3              Rhabdoid meningioma                                      9538/3

  9540/3              Epithelioid MPNST                                        9540/3

  9540/3              Malignant peripheral nerve sheath tumor                  9540/3

  9540/3              Melanotic MPNST                                          9540/3

  9540/3              Melanotic psammomatous MPNST                             9540/3

  9540/3              MPNST with glandular differentiation                     9540/3

  9540/3              MPNST with mesenchymal differentiation                   9540/3

  9540/3              MPNST, NOS                                               9540/3

  9561/3              Malignant peripheral nerve sheath tumor with             9561/3
                      rhabdomyoblastic differentiation                         

  9561/3              MPNST with rhabdomyoblastic differentiation              9561/3

  \-\-\-\-\-\-\-\--   Perineural MPNST                                         9571/3

  \-\-\-\-\-\-\-\--   Perineurioma, malignant                                  9571/3

  9594/3              Microglioma (C71.\_) \[obs\]                             9590/3

  9591/3              B cell lymphoma, NOS                                     9591/3

  9592/3              Lymphosarcoma, diffuse \[obs\]                           9591/3

  9592/3              Lymphosarcoma, NOS \[obs\]                               9591/3

  9672/3              Malignant lymphoma, cleaved cell, NOS \[obs\]            9591/3

  9595/3              Malignant lymphoma, diffuse, NOS                         9591/3

  9694/3              Malignant lymphoma, lymphocytic, intermediate            9591/3
                      differentiation, nodular \[obs\]                         

  9672/3              Malignant lymphoma, lymphocytic, poorly                  9591/3
                      differentiated, diffuse \[obs\]                          

  9686/3              Malignant lymphoma, small cell, noncleaved, diffuse      9591/3
                      \[obs\]                                                  

  9672/3              Malignant lymphoma, small cleaved cell, diffuse          9591/3
                      \[obs\]                                                  

  9672/3              Malignant lymphoma, small cleaved cell, NOS \[obs\]      9591/3

  9686/3              Malignant lymphoma, undifferentiated cell type, NOS      9591/3
                      \[obs\]                                                  

  9686/3              Malignant lymphoma, undifferentiated cell,               9591/3
                      non-Burkitt \[obs\]                                      

  9593/3              Reticulosarcoma, diffuse \[obs\]                         9591/3

  9593/3              Reticulosarcoma, NOS \[obs\]                             9591/3

  9593/3              Reticulum cell sarcoma, diffuse \[obs\]                  9591/3

  9593/3              Reticulum cell sarcoma, NOS \[obs\]                      9591/3

  \-\-\-\-\-\-\-\--   Composite Hodgkin and non-Hodgkin lymphoma               9596/3

  \-\-\-\-\-\-\-\--   Classical Hodgkin lymphoma, lymphocyte-rich              9651/3

  9658/3              Hodgkin disease, lymphocyte predominance, diffuse        9651/3
                      \[obs\]                                                  

  9657/3              Hodgkin disease, lymphocyte predominance, NOS            9651/3
                      \[obs\]                                                  

  9657/3              Hodgkin disease, lymphocytic-histiocytic                 9651/3
                      predominance \[obs\]                                     

  \-\-\-\-\-\-\-\--   Hodgkin lymphoma, lymphocyte-rich                        9651/3

  9652/3              Classical Hodgkin lymphoma, mixed cellularity, NOS       9652/3

  9653/3              Classical Hodgkin lymphoma, lymphocyte depletion,        9653/3
                      NOS                                                      

  9654/3              Classical Hodgkin lymphoma, lymphocyte depletion,        9654/3
                      diffuse fibrosis                                         

  9655/3              Classical Hodgkin lymphoma, lymphocyte depletion,        9655/3
                      reticular                                                

  9660/3              Hodgkin paragranuloma, nodular \[obs\]                   9659/3

  9660/3              Hodgkin paragranuloma, NOS \[obs\]                       9659/3

  9663/3              Classical Hodgkin lymphoma, nodular sclerosis, NOS       9663/3

  9664/3              Classical Hodgkin lymphoma, nodular sclerosis,           9664/3
                      cellular phase                                           

  9665/3              Classical Hodgkin lymphoma, nodular sclerosis, grade     9665/3
                      1                                                        

  9666/3              Hodgkin disease, nodular sclerosis, mixed                9665/3
                      cellularity                                              

  9665/3              Hodgkin lymphoma, nodular sclerosis, grade 1             9665/3

  9667/3              Classical Hodgkin lymphoma, nodular sclerosis, grade     9667/3
                      2                                                        

  9667/3              Hodgkin lymphoma, nodular sclerosis, grade 2             9667/3

  9670/3              Malignant lymphoma, small B lymphocytic, NOS (See        9670/3
                      also M-9823/3)                                           

  9670/3              Malignant lymphoma, small cell diffuse                   9670/3

  9670/3              Malignant lymphoma, small lymphocytic, NOS               9670/3

  9674/3              Malignant lymphoma, centrocytic \[obs\]                  9673/3

  9677/3              Malignant lymphomatous polyposis \[obs\]                 9673/3

  9673/3              Mantle cell lymphoma                                     9673/3

  9676/3              Malignant lymphoma, centroblastic-centrocytic,           9675/3
                      diffuse \[obs\]                                          

  9676/3              Malignant lymphoma, centroblastic-centrocytic, NOS       9675/3
                      \[obs\]                                                  

  \-\-\-\-\-\-\-\--   Primary effusion lymphoma                                9678/3

  \-\-\-\-\-\-\-\--   Mediastinal large B-cell lymphoma (C38.3)                9679/3

  \-\-\-\-\-\-\-\--   Thymic large B-cell lymphoma (C37.9)                     9679/3

  9680/3              Anaplastic large B-cell lymphoma                         9680/3

  9712/3              Angioendotheliomatosis                                   9680/3

  9680/3              Angiotropic lymphoma                                     9680/3

  9680/3              Histiocyte-rich large B-cell lymphoma                    9680/3

  9680/3              Intravascular B-cell lymphoma                            9680/3

  9680/3              Intravascular large B-cell lymphoma (C49.9)              9680/3

  9683/3              Malignant lymphoma, centroblastic, diffuse               9680/3

  9683/3              Malignant lymphoma, centroblastic, NOS                   9680/3

  9680/3              Malignant lymphoma, large B-cell, diffuse,               9680/3
                      centroblastic, NOS                                       

  9681/3              Malignant lymphoma, large cell, cleaved, diffuse         9680/3

  9681/3              Malignant lymphoma, large cell, cleaved, NOS             9680/3

  9682/3              Malignant lymphoma, large cell, noncleaved, diffuse      9680/3

  9682/3              Malignant lymphoma, large cell, noncleaved, NOS          9680/3

  9681/3              Malignant lymphoma, large cleaved cell, NOS              9680/3

  9682/3              Malignant lymphoma, noncleaved, diffuse, NOS             9680/3

  9682/3              Malignant lymphoma, noncleaved, NOS                      9680/3

  9688/3 \*           T-cell rich large B-cell lymphoma                        9680/3

  9680/3              T-cell rich/histiocyte-rich large B-cell lymphoma        9680/3

  9684/3              Malignant lymphoma, large B-cell, diffuse,               9684/3
                      immunoblastic, NOS                                       

  9684/3              Plasmablastic lymphoma                                   9684/3

  9687/3              Burkitt-like lymphoma                                    9687/3

  \-\-\-\-\-\-\-\--   Splenic lymphoma with villous lymphocytes (C42.2)        9689/3

  \-\-\-\-\-\-\-\--   Splenic marginal zone B-cell lymphoma (C42.2)            9689/3

  \-\-\-\-\-\-\-\--   Splenic marginal zone lymphoma, NOS (C42.2)              9689/3

  9690/3              Follicular lymphoma, NOS (See also M-9675/3)             9690/3

  9692/3              Malignant lymphoma, centroblastic-centrocytic,           9690/3
                      follicular                                               

  9690/3              Malignant lymphoma, follicle center, follicular          9690/3

  9690/3              Malignant lymphoma, follicle center, NOS                 9690/3

  9691/3              Follicular lymphoma, grade 2                             9691/3

  9695/3              Follicular lymphoma, grade 1                             9695/3

  9696/3              Malignant lymphoma, lymphocytic, poorly                  9695/3
                      differentiated, nodular \[obs\]                          

  9698/3              Follicular lymphoma, grade 3                             9698/3

  9697/3              Malignant lymphoma, centroblastic, follicular            9698/3

  9693/3              Malignant lymphoma, lymphocytic, well                    9698/3
                      differentiated, nodular \[obs\]                          

  \-\-\-\-\-\-\-\--   BALT lymphoma                                            9699/3

  \-\-\-\-\-\-\-\--   Bronchial-associated lymphoid tissue lymphoma            9699/3

  9715/3 \*           MALT lymphoma                                            9699/3

  \-\-\-\-\-\-\-\--   Marginal zone B-cell lymphoma, NOS                       9699/3

  9710/3 \*           Marginal zone lymphoma, NOS                              9699/3

  9711/3              Monocytoid B-cell lymphoma                               9699/3

  9715/3 \*           Mucosal-associated lymphoid tissue lymphoma              9699/3

  \-\-\-\-\-\-\-\--   Nodal marginal zone lymphoma                             9699/3

  \-\-\-\-\-\-\-\--   SALT lymphoma                                            9699/3

  \-\-\-\-\-\-\-\--   Skin-associated lymphoid tissue lymphoma                 9699/3

  9700/3              Pagetoid reticulosis                                     9700/3

  9704/3              Lennert lymphoma                                         9702/3

  9704/3              Lymphoepithelioid lymphoma                               9702/3

  9702/3              Mature T-cell lymphoma, NOS                              9702/3

  9702/3              Peripheral T-cell lymphoma, large cell                   9702/3

  9707/3              Peripheral T-cell lymphoma, pleomorphic medium and       9702/3
                      large cell                                               

  9706/3              Peripheral T-cell lymphoma, pleomorphic small cell       9702/3

  9702/3              T-cell lymphoma, NOS                                     9702/3

  9703/3              T-zone lymphoma                                          9702/3

  \-\-\-\-\-\-\-\--   Subcutaneous panniculitis-like T-cell lymphoma           9708/3

  9709/3              Cutaneous T-cell lymphoma, NOS (C44.\_)                  9709/3

  9714/3              Anaplastic large cell lymphoma, CD30+                    9714/3

  9714/3              Anaplastic large cell lymphoma, NOS                      9714/3

  9714/3              Anaplastic large cell lymphoma, T cell and Null cell     9714/3
                      type                                                     

  \-\-\-\-\-\-\-\--   Hepatosplenic gamma-delta cell lymphoma                  9716/3

  \-\-\-\-\-\-\-\--   Enteropathy associated T-cell lymphoma                   9717/3

  \-\-\-\-\-\-\-\--   Enteropathy type intestinal T-cell lymphoma              9717/3

  \-\-\-\-\-\-\-\--   Intestinal T-cell lymphoma                               9717/3

  \-\-\-\-\-\-\-\--   Lymphomatoid papulosis (C44.\_)                          9718/3

  \-\-\-\-\-\-\-\--   Primary cutaneous anaplastic large cell lymphoma         9718/3
                      (C44.\_)                                                 

  \-\-\-\-\-\-\-\--   Primary cutaneous CD30+ large T-cell lymphoma            9718/3
                      (C44.\_)                                                 

  \-\-\-\-\-\-\-\--   Primary cutaneous CD30+ T-cell lymphoproliferative       9718/3
                      disorder (C44.\_)                                        

  9713/3              Angiocentric T-cell lymphoma \[obs\]                     9719/3

  9713/3              Malignant midline reticulosis \[obs\]                    9719/3

  9713/3              Malignant reticulosis, NOS \[obs\]                       9719/3

  \-\-\-\-\-\-\-\--   NK/T-cell lymphoma, nasal and nasal-type                 9719/3

  9713/3              Polymorphic reticulosis \[obs\]                          9719/3

  \-\-\-\-\-\-\-\--   T/NK-cell lymphoma                                       9719/3

  9685/3              Lymphoblastoma \[obs\]                                   9727/3

  9685/3              Malignant lymphoma, convoluted cell \[obs\]              9727/3

  9685/3              Malignant lymphoma, lymphoblastic (See also 9821/3)      9727/3

  \-\-\-\-\-\-\-\--   Precursor cell lymphoblastic lymphoma, NOS (See also     9727/3
                      M-9835/3)                                                

  \-\-\-\-\-\-\-\--   Precursor B-cell lymphoblastic lymphoma (See also        9728/3
                      M-9836/3)                                                

  \-\-\-\-\-\-\-\--   Precursor T-cell lymphoblastic lymphoma (See also        9729/3
                      M-9837/3)                                                

  9731/3              Plasmacytoma of bone (C40.\_, C41.\_)                    9731/3

  9830/3              Plasma cell leukemia (C42.1)                             9733/3

  9830/3              Plasmacytic leukemia (C42.1)                             9733/3

  9731/3              Plasmacytoma, extramedullary (not occurring in bone)     9734/3

  9900/3              Mast cell leukemia (C42.1)                               9742/3

  9720/3              Histiocytic medullary reticulosis \[obs\]                9750/3

  9720/3              Malignant histiocytosis                                  9750/3

  9722/3              Acute progressive histiocytosis X                        9754/3

  \-\-\-\-\-\-\-\--   Langerhans cell histiocytosis, disseminated              9754/3

  \-\-\-\-\-\-\-\--   Langerhans cell histiocytosis, generalized               9754/3

  9722/3              Letterer-Siwe disease                                    9754/3

  9722/3              Nonlipid reticuloendotheliosis \[obs\]                   9754/3

  \-\-\-\-\-\-\-\--   Histiocytic sarcoma                                      9755/3

  9723/3              True histiocytic lymphoma \[obs\]                        9755/3

  \-\-\-\-\-\-\-\--   Langerhans cell sarcoma                                  9756/3

  \-\-\-\-\-\-\-\--   Dendritic cell sarcoma, NOS                              9757/3

  \-\-\-\-\-\-\-\--   Interdigitating cell sarcoma                             9757/3

  \-\-\-\-\-\-\-\--   Interdigitating dendritic cell sarcoma                   9757/3

  \-\-\-\-\-\-\-\--   Follicular dendritic cell sarcoma                        9758/3

  \-\-\-\-\-\-\-\--   Follicular dendritic cell tumor                          9758/3

  9763/3              Franklin disease                                         9762/3

  9763/3              Gamma heavy chain disease                                9762/3

  9762/3              Heavy chain disease, NOS                                 9762/3

  9762/3              Mu heavy chain disease                                   9762/3

  9804/3              Aleukemic leukemia, NOS \[obs\]                          9800/3

  9803/3              Chronic leukemia, NOS \[obs\]                            9800/3

  9802/3              Subacute leukemia, NOS \[obs\]                           9800/3

  9801/3              Stem cell leukemia                                       9801/3

  \-\-\-\-\-\-\-\--   Acute bilineal leukemia                                  9805/3

  \-\-\-\-\-\-\-\--   Acute biphenotypic leukemia                              9805/3

  \-\-\-\-\-\-\-\--   Acute mixed lineage leukemia                             9805/3

  9824/3              Aleukemic lymphatic leukemia \[obs\]                     9820/3

  9824/3              Aleukemic lymphocytic leukemia \[obs\]                   9820/3

  9824/3              Aleukemic lymphoid leukemia \[obs\]                      9820/3

  9850/3              Lymphosarcoma cell leukemia \[obs\]                      9820/3

  9822/3              Subacute lymphatic leukemia \[obs\]                      9820/3

  9822/3              Subacute lymphocytic leukemia \[obs\]                    9820/3

  9822/3              Subacute lymphoid leukemia \[obs\]                       9820/3

  9823/3              B-cell chronic lymphocytic leukemia/small                9823/3
                      lymphocytic lymphoma (See also M-9670/3)                 

  9823/3              Chronic lymphocytic leukemia, B-cell type (includes      9823/3
                      all variants of BCLL)                                    

  9826/3              Acute lymphoblastic leukemia, mature B-cell type         9826/3

  9826/3              B-ALL \[obs\]                                            9826/3

  9826/3              Burkitt cell leukemia (See also M-9687/3)                9826/3

  9826/3              FAB L3 \[obs\]                                           9826/3

  9827/3              Adult T-cell leukemia/lymphoma (HTLV-1 positive)         9827/3
                      Includes all variants                                    

  9825/3              Prolymphocytic leukemia, NOS                             9832/3

  \-\-\-\-\-\-\-\--   Prolymphocytic leukemia, B-cell type                     9833/3

  \-\-\-\-\-\-\-\--   Prolymphocytic leukemia, T-cell type                     9834/3

  9821/3              Acute lymphatic leukemia                                 9835/3

  9828/3 \*\*         Acute lymphoblastic leukemia, L2 type, NOS               9835/3

  9821/3              Acute lymphoblastic leukemia, NOS (See also              9835/3
                      M-9727/3)                                                

  \-\-\-\-\-\-\-\--   Acute lymphoblastic leukemia, precursor-cell type        9835/3

  \-\-\-\-\-\-\-\--   Acute lymphoblastic leukemia-lymphoma, NOS               9835/3

  9821/3              Acute lymphocytic leukemia                               9835/3

  9821/3              Acute lymphoid leukemia                                  9835/3

  9821/3              FAB L1                                                   9835/3

  9828/3 \*\*         FAB L2                                                   9835/3

  9821/3              Lymphoblastic leukemia, NOS                              9835/3

  \-\-\-\-\-\-\-\--   Precursor cell lymphoblastic leukemia, NOS (See also     9835/3
                      M-9727/3)                                                

  \-\-\-\-\-\-\-\--   Precursor cell lymphoblastic leukemia, not               9835/3
                      phenotyped                                               

  \-\-\-\-\-\-\-\--   c-ALL                                                    9836/3

  \-\-\-\-\-\-\-\--   Common ALL                                               9836/3

  \-\-\-\-\-\-\-\--   Common precursor B ALL                                   9836/3

  \-\-\-\-\-\-\-\--   Pre-B ALL                                                9836/3

  \-\-\-\-\-\-\-\--   Precursor B-cell lymphoblastic leukemia                  9836/3

  \-\-\-\-\-\-\-\--   Pre-pre-B ALL                                            9836/3

  \-\-\-\-\-\-\-\--   Pro-B ALL                                                9836/3

  \-\-\-\-\-\-\-\--   Cortical T ALL                                           9837/3

  \-\-\-\-\-\-\-\--   Mature T ALL                                             9837/3

  \-\-\-\-\-\-\-\--   Precursor T-cell lymphoblastic leukemia                  9837/3

  \-\-\-\-\-\-\-\--   Pre-T ALL                                                9837/3

  \-\-\-\-\-\-\-\--   Pro-T ALL                                                9837/3

  9841/3              Acute erythremia \[obs\]                                 9840/3

  9841/3              Acute erythremic myelosis \[obs\]                        9840/3

  9840/3              Acute erythroid leukemia                                 9840/3

  9840/3              Acute myeloid leukemia, M6 type                          9840/3

  9840/3              AML M6                                                   9840/3

  9841/3              Di Guglielmo disease \[obs\]                             9840/3

  9840/3              FAB M6                                                   9840/3

  9840/3              M6A                                                      9840/3

  9840/3              M6B                                                      9840/3

  9864/3              Aleukemic granulocytic leukemia \[obs\]                  9860/3

  9894/3              Aleukemic monocytic leukemia \[obs\]                     9860/3

  9864/3              Aleukemic myelogenous leukemia \[obs\]                   9860/3

  9864/3              Aleukemic myeloid leukemia \[obs\]                       9860/3

  9893/3              Chronic monocytic leukemia \[obs\]                       9860/3

  9880/3              Eosinophilic leukemia                                    9860/3

  9890/3              Monocytic leukemia, NOS                                  9860/3

  9860/3              Non-lymphocytic leukemia, NOS                            9860/3

  9862/3              Subacute granulocytic leukemia \[obs\]                   9860/3

  9892/3              Subacute monocytic leukemia \[obs\]                      9860/3

  9862/3              Subacute myelogenous leukemia \[obs\]                    9860/3

  9862/3              Subacute myeloid leukemia \[obs\]                        9860/3

  9861/3              Acute myeloid leukemia, NOS (FAB or WHO type not         9861/3
                      specified) (See also M-9930/3)                           

  9861/3              Acute non-lymphocytic leukemia                           9861/3

  9866/3              Acute myeloid leukemia, PML/RAR-alpha                    9866/3

  9866/3              Acute myeloid leukemia, t(15;17)(q22;q11-12)             9866/3

  9866/3              Acute promyelocytic leukemia, PML/RAR-alpha              9866/3

  9866/3              Acute promyelocytic leukemia, t(15;17)(q22;q11-12)       9866/3

  9866/3              FAB M3 (includes all variants)                           9866/3

  9867/3              FAB M4                                                   9867/3

  9870/3              Acute basophilic leukemia                                9870/3

  \-\-\-\-\-\-\-\--   Acute myeloid leukemia with abnormal marrow              9871/3
                      eosinophils (includes all variants)                      

  \-\-\-\-\-\-\-\--   Acute myeloid leukemia, CBF-beta/MYH11                   9871/3

  \-\-\-\-\-\-\-\--   Acute myeloid leukemia, inv(16)(p13;q22)                 9871/3

  \-\-\-\-\-\-\-\--   Acute myeloid leukemia, t(16;16)(p13;q11)                9871/3

  \-\-\-\-\-\-\-\--   Acute myelomonocytic leukemia with abnormal              9871/3
                      eosinophils                                              

  9871/3 \*\*         FAB M4Eo                                                 9871/3

  9869/3 \*\*         Acute myeloblastic leukemia                              9872/3

  \-\-\-\-\-\-\-\--   Acute myeloid leukemia, minimal differentiation          9872/3

  9872/3 \*\*         FAB M0                                                   9872/3

  \-\-\-\-\-\-\-\--   Acute myeloid leukemia without maturation                9873/3

  9873/3 \*\*         FAB M1                                                   9873/3

  9865/3 \*\*         Acute myelocytic leukemia with maturation                9874/3

  \-\-\-\-\-\-\-\--   Acute myeloid leukemia with maturation                   9874/3

  9874/3 \*\*         FAB M2, NOS                                              9874/3

  \-\-\-\-\-\-\-\--   Chronic granulocytic leukemia, BCR/ABL                   9875/3

  \-\-\-\-\-\-\-\--   Chronic granulocytic leukemia, Philadelphia              9875/3
                      chromosome (Ph1) positive                                

  \-\-\-\-\-\-\-\--   Chronic granulocytic leukemia, t(9;22)(q34;q11)          9875/3

  \-\-\-\-\-\-\-\--   Chronic myelogenous leukemia, BCR/ABL positive           9875/3

  \-\-\-\-\-\-\-\--   Chronic myelogenous leukemia, Philadelphia               9875/3
                      chromosome (Ph1) positive                                

  \-\-\-\-\-\-\-\--   Chronic myelogenous leukemia, t(9;22)(q34;q11)           9875/3

  \-\-\-\-\-\-\-\--   Atypical chronic myeloid leukemia, BCR/ABL negative      9876/3

  \-\-\-\-\-\-\-\--   Atypical chronic myeloid leukemia, Philadelphia          9876/3
                      chromosome (Ph1) negative                                

  9891/3              FAB M5 (includes all variants)                           9891/3

  \-\-\-\-\-\-\-\--   Acute myeloid leukemia with multilineage dysplasia       9895/3
                      (See also M-9984/3)                                      

  \-\-\-\-\-\-\-\--   Acute myeloid leukemia with prior myelodysplastic        9895/3
                      syndrome                                                 

  \-\-\-\-\-\-\-\--   Acute myeloid leukemia without prior myelodysplastic     9895/3
                      syndrome                                                 

  \-\-\-\-\-\-\-\--   Acute myeloid leukemia, AML1(CBF-alpha)/ETO              9896/3

  \-\-\-\-\-\-\-\--   Acute myeloid leukemia, t(8;21) (q22;q22)                9896/3

  \-\-\-\-\-\-\-\--   FAB M2, AML1(CBF-alpha)/ETO                              9896/3

  \-\-\-\-\-\-\-\--   FAB M2, t(8;21)(q22;q22)                                 9896/3

  \-\-\-\-\-\-\-\--   Acute myeloid leukemia, 11q23 abnormalities              9897/3

  \-\-\-\-\-\-\-\--   Acute myeloid leukemia, MLL                              9897/3

  9910/3              FAB M7                                                   9910/3

  \-\-\-\-\-\-\-\--   Therapy-related acute myeloid leukemia and               9920/3
                      myelodysplastic syndrome, NOS                            

  \-\-\-\-\-\-\-\--   Therapy-related acute myeloid leukemia, alkylating       9920/3
                      agent related                                            

  \-\-\-\-\-\-\-\--   Therapy-related acute myeloid leukemia,                  9920/3
                      epipodophyllotoxin-related                               

  9930/3              Myeloid sarcoma (See also M-9861/3)                      9930/3

  9932/3              Acute myelofibrosis                                      9931/3

  9931/3              Acute myelosclerosis                                     9931/3

  9931/3              Acute panmyelosis with myelofibrosis (C42.1)             9931/3

  9931/3              Malignant myelosclerosis \[obs\]                         9931/3

  9940/3              Hairy cell leukemia variant                              9940/3

  9941/3              Leukemic reticuloendotheliosis                           9940/3

  \-\-\-\-\-\-\-\--   Chronic myelomonocytic leukemia in transformation        9945/3
                      \[obs\]                                                  

  9868/3              Chronic myelomonocytic leukemia, NOS                     9945/3

  \-\-\-\-\-\-\-\--   Chronic myelomonocytic leukemia, Type I                  9945/3

  \-\-\-\-\-\-\-\--   Chronic myelomonocytic leukemia, Type II                 9945/3

  \-\-\-\-\-\-\-\--   Juvenile chronic myelomonocytic leukemia                 9946/3

  \-\-\-\-\-\-\-\--   Juvenile myelomonocytic leukemia                         9946/3

  \-\-\-\-\-\-\-\--   Aggressive NK-cell leukemia                              9948/3

  9842/3              Chronic erythremia \[obs\]                               9950/3

  9950/1              Polycythemia rubra vera                                  9950/3

  9950/1              Polycythemia vera                                        9950/3

  9950/3              Proliferative polycythemia                               9950/3

  9960/1              Chronic myeloproliferative disease, NOS                  9960/3

  9960/1              Chronic myeloproliferative disorder                      9960/3

  9961/3              Agnogenic myeloid metaplasia                             9961/3

  9961/3              Chronic idiopathic myelofibrosis                         9961/3

  9961/1              Megakaryocytic myelosclerosis                            9961/3

  9961/3              Myelofibrosis as a result of myeloproliferative          9961/3
                      disease                                                  

  9961/1              Myelofibrosis with myeloid metaplasia                    9961/3

  9961/1              Myelosclerosis with myeloid metaplasia                   9961/3

  9962/1              Essential hemorrhagic thrombocythemia                    9962/3

  9962/1              Essential thrombocythemia                                9962/3

  9962/1              Idiopathic hemorrhagic thrombocythemia                   9962/3

  9962/1              Idiopathic thrombocythemia                               9962/3

  \-\-\-\-\-\-\-\--   Chronic neutrophilic leukemia                            9963/3

  \-\-\-\-\-\-\-\--   Chronic eosinophilic leukemia                            9964/3

  \-\-\-\-\-\-\-\--   Hypereosinophilic syndrome                               9964/3

  9980/1              Refractory anemia                                        9980/3

  9981/1              Refractory anemia without sideroblasts                   9980/3

  9982/3              RARS                                                     9982/3

  9982/1              Refractory anemia with ringed sideroblasts               9982/3

  9982/1              Refractory anemia with sideroblasts                      9982/3

  9983/3              RAEB                                                     9983/3

  9983/3              RAEB I                                                   9983/3

  9983/3              RAEB II                                                  9983/3

  9983/1              Refractory anemia with excess blasts                     9983/3

  9984/3              RAEB-T                                                   9984/3

  9984/1              Refractory anemia with excess blasts in                  9984/3
                      transformation                                           

  \-\-\-\-\-\-\-\--   Refractory cytopenia with multilineage dysplasia         9985/3

  \-\-\-\-\-\-\-\--   Myelodysplastic syndrome with 5q- syndrome               9986/3

  \-\-\-\-\-\-\-\--   Therapy-related myelodysplastic syndrome, alkylating     9987/3
                      agent related                                            

  \-\-\-\-\-\-\-\--   Therapy-related myelodysplastic syndrome,                9987/3
                      epidopophyllotoxin-related                               

  \-\-\-\-\-\-\-\--   Therapy-related myelodysplastic syndrome, NOS            9987/3
  ------------------- ---------------------------------------------------- --- -------------